Risk determination system

Abstract

To provide a risk determination system which computes compliance rates by every drug for each medicated patient based on medicated patient identification information, medication identification information, medication period information, blank period information, and compliance rate computation rules, and stores the compliance rates in association with the medication identification information.SOLUTION: A risk determination system is provided, comprising a compliance rate computation unit configured to compute compliance rates by every drug for each medicated patient based on medicated patient identification information, medication identification information, medication period information, blank period information, and compliance rate computation rules, and a compliance rate storage unit configured to store the compliance rates computed by the compliance rate computation unit in association with the medication identification information.SELECTED DRAWING: Figure 3

Description

[Technical field]

[0001] The present invention relates to a risk assessment system that calculates compliance rates for each drug for each drug recipient based on drug recipient identification information, drug identification information, drug taking period information, blank period information, and compliance rate calculation rules, and stores the compliance rates in association with the drug identification information. [Background technology]

[0002] Recently, systems and services that encourage patients to take medication as prescribed by prescription or other means to comply with the instructions have been considered.

[0003] As an example of such a system, an invention described in Patent Document 1 has been proposed. This invention provides a system that receives medication information entered by a user from a terminal, calculates a score based on the medication information and the user's medication history to evaluate how well the user is following the dosage and administration instructions, and sends compensation information to the user's terminal based on the score. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Patent Publication No. 2021-177330 Summary of the Invention [Problem to be solved by the invention]

[0005] However, the above-mentioned invention has the drawback that the user (medicine taker) must send their own medication information from their terminal to the system each time, and there is no clear disclosure of a method for the system to calculate a score based on the medication information and the user's (medicine taker's) medication history to evaluate how well the user (medicine taker) is following the dosage and usage instructions. [Means for solving the problem]

[0006] In consideration of the above-mentioned problems, the present invention aims to provide a risk assessment system that calculates compliance rates for each drug for each drug recipient based on drug recipient identification information, drug identification information, drug taking period information, blank period information, and compliance rate calculation rules, and stores the compliance rates in association with the drug identification information.

[0007] Specifically, the present invention provides a drug delivery history information storage unit that stores drug delivery history information for a drug recipient identified by the drug recipient identification information stored in the drug recipient identification information storage unit, a previous prescription date information acquisition unit that acquires previous prescription date information indicating the prescription date of a drug identified by the previous drug identification information for a drug recipient identified by the drug recipient identification information, the previous prescription date information being associated with the drug identification information of a delivered drug, a current prescription date information acquisition unit that acquires current prescription date information indicating the prescription date of a drug identified by the current drug identification information for a drug recipient identified by the drug recipient identification information, the current prescription date information being associated with the drug identification information of a delivered drug, and a medication period information acquisition unit that acquires certain medication period information from pharmaceutical delivery history information; a medication period information storage unit that stores the medication period information acquired by the medication period information acquisition unit in association with medication identification information; a blank period information acquisition unit that acquires blank period information from pharmaceutical delivery history information in association with medication identification information that identifies a medication to be delivered, the blank period information being information representing a period from a previous prescription date to a current prescription date during which no medication that should theoretically be taken exists; and a blank period information storage unit that stores the blank period information acquired by the blank period information acquisition unit in association with the medication identification information. The risk assessment system includes: a compliance rate calculation rule holding unit that holds, in association with drug identification information, compliance rate calculation rules, which are rules for calculating a compliance rate indicating that a drug user is taking a target drug in compliance with the dosage and administration instructions, based on medication period information and blank period information; a compliance rate calculation unit that calculates a compliance rate for each drug for each drug user, based on the drug user identification information, drug identification information, medication period information, blank period information, and the compliance rate calculation rules; and a compliance rate holding unit that holds the compliance rates calculated by the compliance rate calculation unit in association with the drug identification information.

[0008] In addition to the above-mentioned characteristics, the present invention provides a risk assessment system having a statistical processing unit that performs statistical processing of the compliance rate stored in the compliance rate storage unit for each drug identification information, a statistical processing result storage unit that stores the statistical processing results in the statistical processing unit, and a statistical processing result output unit that outputs the statistical processing results stored in the statistical processing result storage unit.

[0009] The present invention also provides a patient identification information storage unit that stores patient identification information, which is information for uniquely identifying a patient who takes a drug indicated in information related to the provision of medicines; a drug identification information storage unit that stores drug identification information, which is information for uniquely identifying a drug indicated in information related to the provision of medicines; a drug provision history information storage unit that stores history information of information related to the provision of medicines, including drug identification information, for a patient identified by the patient identification information stored in the patient identification information storage unit; a current prescription date information acquisition unit that acquires current prescription date information, which indicates the prescription date of a drug identified by the current drug identification information of a patient identified by the patient identification information, and which is associated with the drug identification information of a provided drug; a past prescription date information acquisition unit that acquires past prescription date information, which indicates the prescription date of a drug identified by past drug identification information of a patient identified by the patient identification information, and which is associated with the drug identification information of a provided drug; and information indicating a period from a past prescription date to a current prescription date, which indicates a period during which a drug that should be taken exists. a medication period information acquisition unit that acquires medication period information from pharmaceutical benefit history information; a medication period information storage unit that stores the medication period information acquired by the medication period information acquisition unit in association with medication identification information; a blank period information acquisition unit that acquires blank period information from pharmaceutical benefit history information, the blank period information being information representing a period from a previous prescription date to a current prescription date during which no medication that should theoretically be taken exists; a blank period information storage unit that stores the blank period information acquired by the blank period information acquisition unit in association with medication identification information; The risk assessment system has: a compliance rate calculation rule holding unit that holds, in association with drug identification information, compliance rate calculation rules, which are rules for calculating a compliance rate indicating that a drug recipient is taking a target drug in compliance with dosage and administration based on the drug recipient identification information; a compliance rate calculation unit that calculates a compliance rate for each drug for each drug recipient based on the drug recipient identification information, drug identification information, drug taking period information, blank period information, and the compliance rate calculation rules; and a compliance rate holding unit that holds the compliance rates calculated by the compliance rate calculation unit in association with the drug identification information.

[0010] In addition to the above-mentioned characteristics, the present invention provides a risk assessment system having a statistical processing unit that performs statistical processing of the compliance rate stored in the compliance rate storage unit for each drug identification information, a statistical processing result storage unit that stores the statistical processing results in the statistical processing unit, and a statistical processing result output unit that outputs the statistical processing results stored in the statistical processing result storage unit.

[0011] In addition to the above-mentioned features, the present invention provides a risk determination system further having a risk information derivation rule holding unit that holds risk information derivation rules, which are rules for deriving risk information representing risks arising from the medication behavior of a medication recipient identified by medication recipient identification information, based on the compliance rate held in the compliance rate holding unit; a medication-recipient-specific drug-specific risk information determination unit that determines risk information for each medication for each medication recipient based on the medication recipient identification information, drug identification information, medication period information, blank period information, compliance rate calculation rules, and the risk information derivation rules; and a risk information holding unit that holds the risk information determined by the medication-recipient-specific drug-specific risk information determination unit in association with the medication recipient identification information and the drug identification information.

[0012] In addition to the above-mentioned features, the present invention provides a risk assessment system which further has an alert notification unit which issues an alert to alert both or either one of a recipient identified by recipient identification information and medical professionals involved with the recipient to pay attention, depending on the risk information held in the risk information holding unit.

[0013] In addition to the above-mentioned characteristics, the present invention provides a risk assessment system further having a medication instruction advice information holding unit that holds advice information regarding medication instructions for the medication prescribed to the medication recipient in association with medication recipient identification information, a medication instruction advice information updating unit that can update the advice information regarding medication instructions held in the medication instruction advice information holding unit in accordance with the risk information held in the risk information holding unit, and a medication instruction advice information output unit that outputs the advice information regarding medication instructions updated by the medication instruction advice information updating unit to both or either of the medication recipient identified by the medication recipient identification information and the medical professional associated with the medication recipient.

[0014] In addition to the above-mentioned features, the present invention provides a risk assessment system which further has a risk information output unit which is capable of outputting the risk information held in the risk information holding unit to the outside based on the consent of a drug recipient identified by the drug recipient identification information.

[0015] In addition to the above-mentioned features, the present invention also provides a risk assessment system in which the medication user identification information includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance card, and a long-term care insurance card number.

[0016] Furthermore, in order to realize the above-mentioned risk assessment system, an operating method of the risk assessment system, which is a computer, and an operating program of the risk assessment system, which is written in a manner that can be read and executed by the risk assessment system, which is a computer, are provided.

[0017] Specifically, the present invention is a method executed by a CPU in a risk determination system which is a computer, the method including: a patient identification information retaining step for retaining patient identification information which is information for uniquely identifying a patient who takes a drug indicated in information related to drug provision; a drug identification information retaining step for retaining drug identification information which is information for uniquely identifying a drug indicated in information related to drug provision; a drug provision history information retaining step for retaining history information of information related to drug provision including drug identification information for a patient identified by the patient identification information retained in the patient identification information retaining step; a previous prescription date information acquiring step for acquiring previous prescription date information which indicates the prescription date of a drug identified by the previous drug identification information for a patient identified by the patient identification information and which is associated with the drug identification information of a provided drug; a current prescription date information acquiring step for acquiring current prescription date information which indicates the prescription date of a drug identified by the current drug identification information for a patient identified by the patient identification information and which is associated with the drug identification information of a provided drug; a medication period information acquisition step for acquiring medication period information from pharmaceutical benefit history information, the medication period information being information representing a period during which a medication that should theoretically be taken exists, which is a period from the date of prescription to the current prescription date; a medication period information storage step for storing the medication period information acquired in the medication period information acquisition step in association with medication identification information; and a blank period information acquisition step for acquiring blank period information from pharmaceutical benefit history information, the blank period information being information representing a period during which a medication that should theoretically be taken does not exist, which is a period from the date of prescription to the current prescription date, in association with medication identification information that identifies the medication to be provided. a blank period information retaining step of retaining the blank period information acquired in the blank period information acquisition step in association with drug identification information; a compliance rate calculation rule retaining step of retaining, in association with drug identification information, compliance rate calculation rules which are rules for calculating an compliance rate showing that a drug recipient is taking a target drug in compliance with dosage and administration based on the drug-taking period information and blank period information; and a compliance rate calculation step of calculating a compliance rate for each drug for each drug recipient based on the drug recipient identification information, drug identification information, drug-taking period information, blank period information, and compliance rate calculation rules.and a compliance rate storage step of storing the compliance rate calculated in the compliance rate calculation step in association with the medication identification information.

[0018] In addition to the above-mentioned characteristics, the present invention also provides a method executed by a CPU in a risk assessment system which is a computer, the method having a statistical processing step of statistically processing the compliance rates stored in the compliance rate storage step for each drug identification information, a statistical processing result storage step of storing the statistical processing results in the statistical processing step, and a statistical processing result output step of outputting the statistical processing results stored in the statistical processing result storage step.

[0019] The present invention also provides a method executed by a CPU in a risk assessment system that is a computer, the method including: a patient identification information retaining step of retaining patient identification information that is information for uniquely identifying a patient who takes a drug indicated in information related to drug provision; a drug identification information retaining step of retaining drug identification information that is information for uniquely identifying a drug indicated in information related to drug provision; a drug provision history information retaining step of retaining history information of information related to drug provision including drug identification information for a patient identified by the patient identification information retained in the patient identification information retaining step; a current prescription date information acquiring step of acquiring current prescription date information that indicates the prescription date of a drug identified by the current drug identification information for a patient identified by the patient identification information and that is associated with the drug identification information of a provided drug; a past prescription date information acquiring step of acquiring past prescription date information that indicates the prescription date of a drug identified by past drug identification information for a patient identified by the patient identification information and that is associated with the drug identification information of a provided drug; A medication period information acquisition step of acquiring medication period information, which is information for indicating a period in which medication exists, from pharmaceutical benefit history information; a medication period information storage step of storing the medication period information acquired in the medication period information acquisition step in association with medication identification information; a blank period information acquisition step of acquiring blank period information, which is information for indicating a period from a past prescription date to a current prescription date in which a medication that should theoretically be taken does not exist, from pharmaceutical benefit history information; and a blank period information storage step of storing the blank period information acquired in the blank period information acquisition step in association with medication identification information. The method includes: a compliance rate calculation rule storage step of storing, in association with drug identification information, compliance rate calculation rules that are rules for calculating a compliance rate showing that a drug recipient is taking a target drug in compliance with dosage and administration instructions, based on the drug recipient identification information, drug identification information, drug taking period information, and blank period information; a compliance rate calculation step of calculating a compliance rate for each drug for each drug recipient, based on the drug recipient identification information, drug identification information, drug taking period information, blank period information, and the compliance rate calculation rule; and a compliance rate storage step of storing the compliance rates calculated in the compliance rate calculation step in association with the drug identification information.

[0020] In addition to the above-mentioned characteristics, the present invention also provides a method executed by a CPU in a risk assessment system which is a computer, the method having a statistical processing step of statistically processing the compliance rates stored in the compliance rate storage step for each drug identification information, a statistical processing result storage step of storing the statistical processing results in the statistical processing step, and a statistical processing result output step of outputting the statistical processing results stored in the statistical processing result storage step.

[0021] In addition to the above-mentioned features, the present invention also provides a method executed by a CPU in a risk assessment system which is a computer, the method further comprising a risk information derivation rule holding step for holding risk information derivation rules which are rules for deriving risk information representing risks arising from the medication behavior of a medication recipient identified by medication recipient identification information based on the compliance rate held in the compliance rate holding step, a medication-recipient-specific drug-specific risk information determination step for determining risk information for each medication for each medication recipient based on the medication recipient identification information, drug identification information, medication period information, blank period information, compliance rate calculation rules, and the risk information derivation rules, and a risk information holding step for retaining the risk information determined in the medication-recipient-specific drug-specific risk information determination step in association with the medication recipient identification information and the drug identification information.

[0022] In addition to the above-mentioned features, the present invention also provides a method executed by a CPU in a risk assessment system which is a computer, and which further has an alert notification step of issuing an alert to alert both or either one of a recipient identified by the recipient identification information and a medical professional associated with the recipient to pay attention, depending on the risk information retained in the risk information retention step.

[0023] In addition to the above-mentioned features, the present invention also provides a method executed by a CPU in a risk assessment system which is a computer, the method further comprising a medication instruction advice information retaining step for retaining advice information regarding medication instructions for a drug prescribed to a patient in association with patient identification information, a medication instruction advice information updating step for updating the advice information regarding medication instructions retained in the medication instruction advice information retaining step in accordance with the risk information retained in the risk information retaining step, and a medication instruction advice information output step for outputting the advice information regarding medication instructions updated in the medication instruction advice information updating step to both or either one of a patient identified by the patient identification information and a medical professional associated with the patient.

[0024] In addition to the above-mentioned features, the present invention also provides a method executed by a CPU in a risk assessment system which is a computer, which further has a risk information output step which can output the risk information retained in the risk information retention step to the outside based on the consent of the drug recipient identified by the drug recipient identification information.

[0025] In addition to the above-mentioned features, the present invention also provides a method executed by a CPU in a risk assessment system which is a computer, wherein the medication recipient identification information includes at least one or more of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a long-term care insurance certificate number.

[0026] Specifically, the present invention includes a patient identification information retaining step for retaining patient identification information which is information for uniquely identifying a patient who takes a drug indicated in information related to the provision of medicines, a drug identification information retaining step for retaining drug identification information which is information for uniquely identifying a drug indicated in information related to the provision of medicines, a drug provision history information retaining step for retaining history information of information related to the provision of medicines including drug identification information for a patient identified by the patient identification information retained in the patient identification information retaining step, a previous prescription date information acquiring step for acquiring previous prescription date information which indicates the prescription date of a drug identified by the previous drug identification information for a patient identified by the patient identification information and which is associated with the drug identification information of a provided drug, a current prescription date information acquiring step for acquiring current prescription date information which indicates the prescription date of a drug identified by the current drug identification information for a patient identified by the patient identification information and which is associated with the drug identification information of a provided drug, and a medication period information acquisition step of acquiring medication period information, which is information on the medication period, from pharmaceutical delivery history information; a medication period information storage step of storing the medication period information acquired in the medication period information acquisition step in association with medication identification information; a blank period information acquisition step of acquiring blank period information, which is information representing a period from a previous prescription date to a current prescription date, in association with medication identification information that identifies a medication to be delivered, from pharmaceutical delivery history information, and which indicates a period during which no medication that should theoretically be taken is present; and a blank period information acquisition step of storing the blank period information acquired in the blank period information acquisition step in association with medication identification information. a compliance rate calculation rule storage step for storing, in association with drug identification information, compliance rate calculation rules which are rules for calculating an compliance rate showing that a drug recipient is taking a target drug in compliance with dosage and administration based on the drug-taking period information and the blank period information; a compliance rate calculation step for calculating a compliance rate for each drug for each drug recipient based on the drug recipient identification information, the drug identification information, the drug-taking period information, the blank period information, and the compliance rate calculation rule; and a compliance rate storage step for storing, in association with the drug identification information, the compliance rates calculated in the compliance rate calculation step.The present invention provides an operating program for a risk determination system, the operating program being written in a readable and executable manner for a risk determination system that is a computer having the above-mentioned.

[0027] In addition to the above-mentioned features, the present invention also provides an operating program for a risk assessment system that is written in a readable and executable manner for a risk assessment system that is a computer having a statistical processing step of statistically processing the compliance rates stored in the compliance rate storage step for each drug identification information, a statistical processing result storage step of storing the results of the statistical processing in the statistical processing step, and a statistical processing result output step of outputting the results of the statistical processing stored in the statistical processing result storage step.

[0028] The present invention also provides a pharmaceutical delivery method comprising: a pharmaceutical delivery history information storage step for storing pharmaceutical delivery history information for a pharmaceutical delivery user identified by the pharmaceutical delivery user identification information stored in the pharmaceutical delivery user identification information storage step; a current prescription date information acquisition step for acquiring current prescription date information indicating a prescription date of a pharmaceutical delivery user identified by the current pharmaceutical delivery information for a pharmaceutical delivery user identified by the pharmaceutical delivery user identification information, the current prescription date information being associated with the pharmaceutical delivery information of a delivered pharmaceutical delivery user; a past prescription date information acquisition step for acquiring past prescription date information indicating a prescription date of a pharmaceutical delivery user identified by the past pharmaceutical delivery information for a pharmaceutical delivery user identified by the pharmaceutical delivery user identification information, the past prescription date information being associated with the pharmaceutical delivery information of a delivered pharmaceutical delivery user; and a pharmaceutical delivery history information storage step for acquiring, from the pharmaceutical delivery history information, medication period information being information indicating a period from a past prescription date to a current prescription date and indicating a period during which a pharmaceutical delivery user should theoretically take a pharmaceutical delivery user. a period information acquisition step, a medication period information storage step for storing medication period information acquired in the medication period information acquisition step in association with medication identification information, a blank period information acquisition step for acquiring blank period information, which is information for indicating a period from a past prescription date to a current prescription date during which there is theoretically no medication to be taken, from pharmaceutical benefit history information, a blank period information storage step for storing the blank period information acquired in the blank period information acquisition step in association with medication identification information, and a blank period information storage step for storing a target medication based on the medication period information and the blank period information, The present invention provides an operating program for a risk assessment system that is written in a readable and executable manner for a risk assessment system that is a computer having: a compliance rate calculation rule storage step for storing compliance rate calculation rules, which are rules for calculating a compliance rate indicating that a patient is taking a drug, in association with drug identification information; a compliance rate calculation step for calculating a compliance rate for each drug for each drug recipient based on drug recipient identification information, drug identification information, drug taking period information, blank period information, and the compliance rate calculation rule; and a compliance rate storage step for storing the compliance rates calculated in the compliance rate calculation step in association with the drug identification information.

[0029] In addition to the above-mentioned features, the present invention also provides an operating program for a risk assessment system that is written in a readable and executable manner for a risk assessment system that is a computer having a statistical processing step of statistically processing the compliance rates stored in the compliance rate storage step for each drug identification information, a statistical processing result storage step of storing the results of the statistical processing in the statistical processing step, and a statistical processing result output step of outputting the results of the statistical processing stored in the statistical processing result storage step.

[0030] In addition to the above-mentioned features, the present invention also provides an operating program for a risk determination system that is written in a manner that can be read and executed by the risk determination system, which is a computer that further has: a risk information derivation rule storage step for storing risk information derivation rules, which are rules for deriving risk information representing risks arising from the medication behavior of a medication recipient identified by medication recipient identification information, based on the compliance rate stored in the compliance rate storage step; a medication-per-medication risk information determination step for determining risk information for each medication for each medication recipient based on the medication recipient identification information, medication identification information, medication period information, blank period information, compliance rate calculation rules, and the risk information derivation rules; and a risk information storage step for storing the risk information determined in the medication-per-medication risk information determination step in association with the medication recipient identification information and the medication identification information.

[0031] In addition to the above-mentioned features, the present invention also provides an operating program for a risk assessment system, which is a computer that further has an alert notification step for issuing an alert to alert both or either one of a user identified by user identification information and medical professionals involved with the user to pay attention, depending on the risk information retained in the risk information retention step.The operating program for the risk assessment system is written in a manner that can be read and executed by the risk assessment system, which is a computer that further has an alert notification step for issuing an alert to both or either one of a user identified by user identification information and medical professionals involved with the user, to pay attention, depending on the risk information retained in the risk information retention step.

[0032] In addition to the above-mentioned features, the present invention also provides an operating program for a risk assessment system, which is written in a manner that can be read and executed by a risk assessment system that is a computer that further has a medication instruction advice information storage step for storing advice information regarding medication instructions for a drug prescribed to a patient in association with patient identification information, a medication instruction advice information update step for updating the advice information regarding medication instructions stored in the medication instruction advice information storage step in accordance with the risk information stored in the risk information storage step, and a medication instruction advice information output step for outputting the advice information regarding medication instructions updated in the medication instruction advice information update step to a patient identified by the patient identification information and / or a medical professional associated with the patient.

[0033] In addition to the above-mentioned features, the present invention also provides an operating program for a risk assessment system, which is written in a readable and executable manner for a risk assessment system, which is a computer that further has a risk information output step that can output the risk information retained in the risk information retention step to the outside based on the consent of a drug recipient identified by the drug recipient identification information.

[0034] In addition to the above-mentioned features, the present invention also provides an operating program for a risk assessment system, which is written in a readable and executable manner for a risk assessment system that is a computer, wherein the medication user identification information includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance card, and a long-term care insurance insured number. Effect of the Invention

[0035] As described above, the present invention provides a risk assessment system that calculates compliance rates for each drug for each drug recipient based on drug recipient identification information, drug identification information, drug taking period information, blank period information, and compliance rate calculation rules, and stores the compliance rates in association with the drug identification information. [Brief description of the drawings]

[0036] [Figure 1]FIG. 1 is a diagram showing a hardware configuration applied to the present invention. [Diagram 2] FIG. 1 is a diagram showing an example of the overall configuration of a risk assessment system according to the present invention. [Diagram 3] FIG. 1 is a diagram showing a functional configuration of a risk determination system according to a first embodiment. [Figure 4] FIG. 1 is a diagram showing a hardware configuration of a risk determination system according to a first embodiment. [Diagram 5] FIG. 1 is a diagram showing a process flow when the risk determination system according to the first embodiment is used. [Figure 6] FIG. 1 shows a functional configuration of a risk determination system according to a second embodiment. [Figure 7] FIG. 13 is a diagram showing a hardware configuration of a risk determination system according to a second embodiment. [Figure 8] FIG. 13 is a diagram showing a process flow when the risk determination system in the second embodiment is used. [Figure 9] FIG. 13 is a diagram showing a functional configuration of a risk determination system according to a third embodiment. [Figure 10] FIG. 13 is a diagram showing a hardware configuration of a risk determination system according to a third embodiment. [Figure 11] FIG. 13 is a diagram showing a process flow when the risk determination system in the third embodiment is used. [Figure 12] FIG. 13 is a diagram showing a functional configuration of a risk determination system according to a fourth embodiment. [Figure 13] FIG. 13 is a diagram showing a hardware configuration of a risk determination system according to a fourth embodiment. [Figure 14] FIG. 13 is a diagram showing a process flow when the risk determination system according to the fourth embodiment is used. [Figure 15] FIG. 13 is a diagram showing a functional configuration of a risk determination system according to a fifth embodiment. [Figure 16] FIG. 13 is a diagram showing a hardware configuration of a risk determination system according to a fifth embodiment. [Figure 17] FIG. 13 is a diagram showing a process flow when the risk determination system in the fifth embodiment is used. [Figure 18] FIG. 13 is a diagram showing a functional configuration of a risk determination system according to a sixth embodiment. [Figure 19] FIG. 13 is a diagram showing a hardware configuration of a risk determination system according to a sixth embodiment. [Figure 20] FIG. 13 is a diagram showing a processing flow when the risk determination system in the sixth embodiment is used. [Figure 21] FIG. 13 is a diagram showing a functional configuration of a risk determination system according to a seventh embodiment. [Figure 22] FIG. 23 is a diagram showing a hardware configuration of a risk determination system according to a seventh embodiment. [Diagram 23] FIG. 13 is a diagram showing a processing flow when the risk determination system in the seventh embodiment is used. [Figure 24] FIG. 13 is a diagram showing a functional configuration of a risk determination system according to an eighth embodiment. [Diagram 25] FIG. 13 is a diagram showing a hardware configuration of a risk determination system according to an eighth embodiment. [Figure 26] FIG. 13 is a diagram showing a processing flow when the risk determination system in the eighth embodiment is used. [Figure 27] FIG. 1 is a diagram showing an example of a compliance rate calculation rule (1) in the present invention. [Figure 28] FIG. 2 is a diagram showing an example of a compliance rate calculation rule (2) in the present invention. [Figure 29] FIG. 1 shows an example of the compliance rate calculation rule (3) in the present invention. [Diagram 30] FIG. 1 is a diagram showing an example of the relationship between users, drugs, and compliance rates in the present invention. [Diagram 31] A diagram showing an example of a risk information derivation rule (in the case of dropout risk) in the present invention. [Diagram 32] FIG. 1 shows an example of the risk of falling off in the present invention (1). [Diagram 33] FIG. 2 shows an example of the risk of falling off in the present invention. [Diagram 34] FIG. 1 is a diagram showing an example of an alert notification according to the present invention. [Diagram 35] FIG. 1 shows an example of medication instruction advice information in the present invention. [Diagram 36] A diagram showing an example of the overall picture (partial excerpt) of a PHR <Hardware that can constitute the present invention>

[0037] FIG. 1 is a diagram showing a hardware configuration applied to the present invention. The present invention is in principle an invention that utilizes a computer, but it can also be realized by software, hardware, or the combination of software and hardware. The hardware that realizes all or part of each of the constituent elements of the present invention is composed of the basic components of a computer, such as a CPU, memory, bus, input / output devices, various peripheral devices, and a user interface. The various peripheral devices include storage devices, interfaces such as the Internet, devices such as the Internet, displays, keyboards, mice, speakers, cameras, videos, televisions, various sensors for grasping the production status in laboratories or factories (flow rate sensors, temperature sensors, weight sensors, liquid volume sensors, infrared sensors, shipment counters, package counters, foreign body inspection devices, defective product counters, radiation inspection devices, surface condition inspection devices, circuit inspection devices, human presence sensors, worker work status grasping devices (with video, ID, PC work volume, etc.)), CD devices, DVD devices, Blu-ray devices, USB memory, USB memory interfaces, removable hard disks, general hard disks, projector devices, SSDs, telephones, fax machines, copy machines, printers, movie editing devices, various sensor devices, etc. In addition, the present system does not necessarily have to be configured by one housing, and may be configured by connecting multiple housings by communication. In addition, communication may be LAN, WAN, Wifi, Bluetooth (registered trademark), infrared communication, or ultrasonic communication, and further, some of the systems may be installed across borders. Furthermore, each of the multiple housings may be operated by a different entity, or may be operated by a single entity. The entity operating the system of the present invention may be single or multiple. The invention may also be configured as a system including, in addition to the present system, a terminal used by a third party, and a terminal used by yet another third party. These terminals may also be installed across borders. Furthermore, in addition to the present system and the terminals, devices used to register related information of third parties, related persons, and databases for recording the contents of registration may be provided. These may be provided in the present system, or may be provided outside the present system to configure the present system so that such information can be used.

[0038] As shown in this diagram, the computer is composed of a chipset, a CPU, a non-volatile memory, a main memory, various buses, a BIOS, various interfaces such as USB, HDMI (registered trademark) and LAN, a real-time clock, etc., which are configured on a motherboard. These operate in cooperation with an operating system, device drivers (for various interfaces such as USB and HDMI (registered trademark), cameras, microphones, speakers or headphones, displays, and other built-in devices), various programs, etc. The various programs and data constituting the present invention are configured to efficiently utilize these hardware resources to execute various processes. Chipset

[0039] A "chipset" is a set of large-scale integrated circuits (LSIs) mounted on a computer's motherboard that integrates a communication function between the CPU's external bus and the standard bus that connects memory and peripheral devices, in other words, a bridge function. There are cases where a two-chipset configuration is used, and cases where a single chipset configuration is used. The side closest to the CPU and main memory is called the northbridge, and the side furthest away, which interfaces with the relatively slow external I / O, is called the southbridge.

[0040] (North Bridge) The northbridge includes a CPU interface, memory controller, and graphics interface. Most of the functions of a conventional northbridge may be handled by the CPU. The northbridge is connected to the main memory's memory slot via a memory bus, and to the graphics card slot of the graphics card via a high-speed graphics bus (AGP, PCI Express).

[0041] (South Bridge) The south bridge is connected to the PCI interface (PCI slot) via the PCI bus, and is responsible for I / O functions such as ATA (SATA) interface, USB interface, and Ethernet interface, as well as sound functions. Incorporating circuits to support PS / 2 ports, floppy disk drives, serial ports, parallel ports, and ISA buses, which do not require or are impossible to operate at high speed, can hinder the speed of the chipset itself, so they can be separated from the south bridge chip and placed in a separate LSI called a super I / O chip. A bus is used to connect the CPU (MPU) to peripheral devices and various control units. The bus is connected by the chipset. The memory bus used to connect to the main memory can instead adopt a channel structure to increase speed. A serial bus or a parallel bus can be used as the bus. While a serial bus transfers data one bit at a time, a parallel bus transmits the original data itself or multiple bits extracted from the original data as a single block and transmits it simultaneously over multiple communication paths. A dedicated line for the clock signal is set up in parallel with the data line to synchronize the data demodulation on the receiving side. It is also used as a bus to connect the CPU (chipset) to external devices, and includes GPIB, IDE / (Parallel)ATA, SCSI, PCI, etc. Since there is a limit to how fast it can be made, in PCI Express, an improved version of PCI, and Serial ATA, an improved version of Parallel ATA, the data line can be a serial bus.

[0042] CPU

[0043] The CPU sequentially reads and interprets and executes a series of instructions called a program in the main memory, and outputs information consisting of signals to the main memory. The CPU functions as the center of calculations in a computer. The CPU is composed of a CPU core part, which is the center of calculations, and its peripheral parts, and includes registers, cache memory, an internal bus connecting the cache memory and the CPU core, a DMA controller, a timer, and an interface with a connection bus to a north bridge. A single CPU (chip) may have multiple CPU cores. In addition to the CPU, processing may be performed by a graphic interface (GPU) or FPU. The embodiment is described as a two-core type, but is not limited to this. A program can also be built into the CPU.

[0044] <Non-volatile memory>

[0045] (HDD)

[0046] The basic structure of a hard disk drive consists of a magnetic disk, a magnetic head, and an arm on which the magnetic head is mounted. The external interface can be SATA (previously ATA). A high-performance controller, such as SCSI, is used to support communication between hard disk drives. For example, when copying a file to another hard disk drive, the controller can read the sectors and transfer them to the other hard disk drive for writing. At this time, the host CPU's memory is not accessed. Therefore, there is no increase in the CPU load.

[0047] <Main memory>

[0048] The CPU directly accesses and executes various programs in main memory. Main memory is a volatile memory that uses DRAM. Programs in main memory are expanded from non-volatile memory to main memory upon receiving a program start command. The CPU then executes the program according to various execution commands and execution procedures within the program.

[0049] Operating System (OS)

[0050] An operating system is used to manage the resources available to applications on a computer, to manage various device drivers, and to manage the computer itself (the hardware). In small computers, firmware may be used as the operating system.

[0051] ≪BIOS≫

[0052] The BIOS causes the CPU to execute procedures for starting up the computer hardware and running the operating system, and is most typically the hardware that the CPU reads first when it receives a computer startup command. The address of the operating system stored on the disk (non-volatile memory) is written here, and the operating system is sequentially loaded into the main memory by the BIOS loaded into the CPU and goes into operation. The BIOS also has a check function for checking the presence or absence of various devices connected to the bus. The check results are stored in the main memory and are made available to the operating system as appropriate. The BIOS may be configured to check external devices, etc. The above is the same for all embodiments.

[0053] As shown in the figure, the present invention can basically be configured with a general-purpose computer program and various devices. The computer basically operates in a form in which a program recorded in non-volatile memory is loaded into main memory, and processing is executed by the main memory, CPU, and various devices. Communication with devices is performed via an interface connected to a bus line. Possible interfaces include a display interface, a keyboard, and a communication buffer. Below, an embodiment of the present invention will be described with reference to the illustrated examples.

[0054] <Satisfying the use of the laws of nature in the present invention>

[0055] The present invention functions in cooperation with a computer, a communication device, and software. Specifically, the present invention relates to a risk assessment system that calculates compliance rates for each drug for each drug recipient based on drug recipient identification information, drug identification information, drug-taking period information, blank period information, and compliance rate calculation rules, and stores the compliance rates in association with drug identification information, and various information and data are exchanged between drug recipient terminals and medical staff terminals via a network using hardware resources. Therefore, from this perspective, if the resources of the present invention, such as a computer, are judged based on the matters described in the claims and the specification and the common general knowledge related to those matters, the present invention as a whole utilizes the laws of nature and is also a computer / software related invention.

[0056] <The significance of using the laws of nature required in patent law>

[0057] The use of the laws of nature required by the Patent Act is required to ensure that an invention can be used industrially and usefully, based on the purpose of the law, from the viewpoint that an invention must have industrial applicability and contribute to the development of industry. In other words, it is required that the invention be industrially useful, that is, that the effect of the invention declared at the time of application can be reproduced with a certain degree of certainty by implementing the invention. From this perspective, the use of the laws of nature is interpreted as the function of each of the invention-specific matters (invention constituent elements), which are the components of the invention for achieving the effect of the invention, being achieved by utilizing the laws of nature. Furthermore, the effect of an invention should be one that has the potential to provide a certain usefulness to the user who uses the invention, and should not be viewed from the perspective of how the user feels or thinks about that usefulness. Therefore, even if the effect that the user obtains from this system is a psychological effect, the effect itself is not subject to the required use of the laws of nature. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0058] Hereinafter, the embodiments of the present invention will be described with reference to the attached drawings. The mutual relationship between the embodiments and the claims is as follows. The explanation of the first embodiment mainly relates to claims 1, 10, and 19, the explanation of the second embodiment mainly relates to claims 2, 11, and 20, the explanation of the third embodiment mainly relates to claims 3, 12, and 21, the explanation of the fourth embodiment mainly relates to claims 4, 13, and 22, the explanation of the fifth embodiment mainly relates to claims 5, 14, and 23, the explanation of the sixth embodiment mainly relates to claims 6, 15, and 24, the explanation of the seventh embodiment mainly relates to claims 7, 16, and 25, and the explanation of the eighth embodiment mainly relates to claims 8, 17, and 26. The present invention should not be limited to these embodiments, and may be implemented in various forms without departing from the spirit of the invention.

[0059] <Overall configuration of the risk assessment system of the present invention> FIG. 2 is a diagram showing an example of the overall configuration of the risk assessment system according to the present invention. The risk determination system 201 is configured to be electrically connected to a recipient terminal 202 and a medical staff terminal 203 via a network 204 (e.g., the Internet, a WAN, a LAN, etc.). Here, the recipient terminal 202 and the medical staff terminal 203 may be electronic devices (e.g., a personal computer, a tablet terminal, a smartphone, etc.) that can be connected to the network 204 via a wired or wireless interface (e.g., a communication cable, a WiFi router, etc.). In addition, in the present invention, the term "medicine recipient" refers to an individual who takes the medicine indicated in the information related to the provision of pharmaceutical products. In some cases, the term "medicine recipient" may include the recipient's family members or caregivers. In addition, the term "healthcare professional" refers to at least one or more of the following: a doctor, a dentist, a pharmacist, a public health nurse, a midwife, a nurse, a licensed practical nurse, a physical therapist, an occupational therapist, an orthoptist, a speech-language-hearing therapist, a prosthetist, a radiologist, a clinical X-ray technician, a clinical laboratory technician, a medical laboratory technician, a clinical engineer, a dental hygienist, a dental technician, a paramedic, an acupressure massage therapist, an acupuncturist, a moxibustion therapist, a judo therapist, a dietitian, a nutritionist, a mental health worker, a social worker, a care worker, a certified psychologist, a clinical psychologist, and a medical administrator. In addition, a medical professional may have the authority to edit, add, or delete various information in the risk assessment system. In addition, "non-medical personnel" refers to at least one or more employees of life insurance companies, non-life insurance companies, securities companies, pharmaceutical companies, drug discovery venture companies, food companies, nursing care service providers, bedding companies, health equipment companies, fitness clubs, sports gyms, banks, credit unions, JA, union health insurance, Association Health Insurance, mutual aid societies, municipal national health insurance, national health insurance associations, PR companies, general research institutes, universities and graduate schools (including affiliated research institutes), technical colleges, agriculture, forestry and fisheries companies, fertilizer companies, government agencies, local governments, and independent administrative agencies. Incidentally, FIG. 36 is a diagram showing an example of the overall picture of a PHR (partial excerpt). As shown in this example, a "PHR system" is a system in which health insurance and medical information held by schools, municipalities, insurers, and medical institutions is stored in an intermediate server or the like, and, based on the consent of individuals (patients and their families, etc.), individuals can view or download their own information by linking it with a system such as "My Number Portal" via API. Note that this is merely an example, and is not necessarily limited to this.

[0060] In addition, in the present invention, it is assumed that the risk assessment system 201 is configured to function on a single physical server, but this is not limited to the above, and the system may be configured so that multiple servers are prepared and information and data are exchanged between them, and the servers work together or cooperate to perform various functions.

[0061] <The social significance of risk assessment systems> First, by utilizing this system, it is possible to grasp the actual situation regarding the patient's medication-taking behavior. In cases where the data (compliance rate) calculated by this system is poor, it can be assumed that there is some problem with taking the drug in question. In such cases, it is possible to alert medical professionals that the patient may not be taking the drug properly. Being able to issue such alerts can promote communication with patients regarding their medication taking status, and encourage the appropriate use of medicines. The above-mentioned alerts can be implemented by linking with other systems that hold prescription information. Secondly, the above-mentioned warnings in this system are not just warnings about the simple status of continued medication; they anticipate possible medication issues that may arise with the target drugs and notify patients of the issues and how to deal with them, thereby improving patients' medication status and promoting appropriate use of drugs, encouraging changes in patients' medication behavior and contributing to the promotion of appropriate use of drugs. Thirdly, by utilizing this system, it is possible to grasp the medication status of multiple medications taken by an individual patient, and understand the trends in the medication behavior of the individual patient, and provide medication instructions according to those trends. In addition, this data on trends can be used in a system that updates and outputs advice to medical professionals on medication instructions for patients, or as one of the parameters for updating algorithms that act as risk information derivation rules. Fourth, by accumulating and analyzing the adherence rate judgments in this system, it is possible to estimate the risk of patients discontinuing medication due to their own judgment. Based on these results, it is also possible to perform a statistical rating of the patient's medication behavior, and this rating can be used as one of the parameters mentioned above. Fifth, by utilizing this system, it is possible to grasp the tendency of the medication status of all patients stored in the medical system (referring to a system of a single facility, a medical information linkage system such as PHR, etc.), and to perform a rating of all patients recorded in the medical system. As a result, the medication status of all patients in the medical system can be statistically generated, and it becomes possible to rate the medication status in the medical system. As a result, it becomes possible to rate the medication status of each medical institution (e.g., hospitals, general clinics, dental clinics, pharmacies, visiting care stations, etc.; the same applies below) and medical facilities (e.g., hospitals, clinics, nursing homes for the elderly, dispensing pharmacies, other facilities providing medical care, etc.; the same applies below). If it becomes possible to rate on a facility-by-facility basis, it can also be used for evaluation of medication instruction at that single facility. In addition, it becomes possible to extract patients with a specific rating and implement measures to change medication behavior for each rating, which can contribute to the promotion of proper use throughout the facility. Promotion of proper use leads to an increase in visits to medical institutions and medical facilities, which can lead to increased sales at medical institutions and medical facilities. These ratings can also be used as indicators of business conditions. In addition, by rating the medication status for each patient / medical institution / healthcare facility, it becomes possible to provide some kind of incentive (such as, but not limited to, the granting of My Number points or the issuance of coupons) to patients with high ratings, which can serve as an opportunity to change patients' medication behavior and contribute to the promotion of appropriate use of medicines. Sixth, by utilizing the data on the dosing status of each drug accumulated in this system, it will be possible to statistically rate the compliance rate of each drug and extract drugs that are thought to have issues with regard to their dosing status. By analyzing the issues with taking the drug, it will be possible to improve the content of materials related to drug guidance and by analyzing the trends of drugs with low ratings, it will be possible to conduct basic research into the development of drugs that patients will find easier to continue taking. Seventh, by utilizing the data on the taking of each drug accumulated in this system, it is possible to statistically rate the compliance rate for each drug. This allows medical institutions and healthcare facilities that use the system to take measures and improve the content of guidance for drugs with low compliance rates or ratings, thereby promoting the appropriate use of those drugs and increasing the frequency of visits by patients to the medical institution or healthcare facility.

[0062] <Embodiment 1 (corresponding mainly to claims 1, 10 and 19)> <Overview of embodiment 1> This embodiment provides a risk determination system that calculates compliance rates for each drug for each drug recipient based on drug recipient identification information, drug identification information, drug-taking period information, blank period information, and compliance rate calculation rules, and stores the compliance rates in association with the drug identification information. In order to achieve this, a method executed by a CPU in the risk determination system, which is a computer, and an operating program for the risk determination system, which is written so as to be readable and executable by the risk determination system, which is a calculator, are provided.

[0063] <Functional configuration of embodiment 1> 3 is a diagram showing the functional configuration of the risk assessment system in embodiment 1. In this embodiment, the risk assessment system includes a medication user identification information storage unit, a medication identification information storage unit, a pharmaceutical delivery history information storage unit, a previous prescription date information acquisition unit, a current prescription date information acquisition unit, a medication period information acquisition unit, a medication period information storage unit, a blank period information acquisition unit, a blank period information storage unit, a compliance rate calculation rule storage unit, a compliance rate calculation unit, and a compliance rate storage unit.

[0064] <Description of the configuration of embodiment 1: Drug recipient identification information storage unit> The 'medicine recipient identification information storage unit' 301 is configured to have a function of storing medication recipient identification information, which is information for uniquely identifying a recipient who takes a drug indicated in information related to the provision of medicines. Here, "information related to the provision of pharmaceuticals" preferably includes information on paper prescriptions or electronic data on electronic prescriptions. There are no particular limitations on the source of information for "information related to the provision of pharmaceuticals." The same applies hereafter. In addition, it is preferable that the "medication user identification information" includes at least one of the following information: My Number information, the symbol and number on the insured person's card for social insurance or national health insurance, and the insured person's number for long-term care insurance. Here, "My Number" refers to a 12-digit "personal number" assigned to each person, from babies to the elderly. Everyone who has a resident card in Japan (including foreigners) has one. Since it is a number unique to that person, no one has the same number, including deceased people.

[0065] <Description of the configuration of embodiment 1: Drug identification information storage unit> The 'medicine identification information storage unit' 302 is configured to have a function of storing medicine identification information, which is information for uniquely identifying a medicine indicated in information related to the provision of medicines. Here, "information related to the provision of pharmaceuticals" preferably includes information on a paper prescription or electronic data on an electronic prescription. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0066] <Description of the configuration of embodiment 1: Pharmaceutical delivery history information storage unit> The 'drug delivery history information storage unit' 303 is configured to have a function of storing history information on information related to the delivery of drugs, including drug identification information, for a drug recipient identified by the stored drug recipient identification information. Here, "information related to the provision of pharmaceuticals" preferably includes information on a paper prescription or electronic data on an electronic prescription. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0067] <Description of the configuration of embodiment 1: Previous prescription date information acquisition unit> The "previous prescription date information acquisition unit" 304 is configured to have a function of acquiring previous prescription date information associated with the drug identification information of the dispensed drug, which is information indicating the prescription date of the drug identified by the previous drug identification information of the drug recipient identified by the drug recipient identification information. Here, the "previous prescription date information" may be acquired from the drug delivery history information stored in the drug delivery history information storage unit described above, or may be acquired via an API from a health and medical information sharing system (including, for example, a PHR system, etc.) or the like. Here, a "healthcare information sharing system" refers to a healthcare information sharing system that includes, for example, a healthcare information storage unit that stores healthcare information about individuals, and an access control unit that allows a third party to access the healthcare information stored in the healthcare information storage unit via a network, the access control unit having access subject-specific requirement request means for imposing different access requirements depending on whether the access subject uses the healthcare information non-commercially or uses the healthcare information commercially, and the healthcare information storage unit refers to a healthcare information sharing system that includes at least one of an individual's electronic medical record information, various test information, prescription information, medical history information, vital information, questionnaire information, data from health promotion apps, and conversation data from interactive health promotion SNS, etc., and the same applies hereinafter. Note that the above is an example of a "healthcare information sharing system" and is not necessarily limited to this. For example, the system may have a health and medical related information storage unit that stores health and medical related information about an individual, an access control unit that causes the health and medical related information stored in the health and medical related information storage unit to be disclosed to a third party via a network, a disclosure permission information holding unit that holds disclosure permission information indicating whether an individual allows their health and medical related information to be disclosed to a third party, and a third party identification information holding unit that holds third party identification information for identifying whether the third party is a medical professional or a non-medical professional, wherein the health and medical related information storage unit stores health and medical related information consisting of the individual's electronic medical record information, various test information, prescription information, medical history information, vital sign information, questionnaire information, data from a health promotion app, and conversation data from an interactive health promotion SNS, and the access control unit varies the scope of the health and medical related information that can be viewed depending on whether the third party is a medical professional or a non-medical professional. For example, the information storage unit may include a health and medical related information storage unit that stores health and medical related information, which is information related to health and medical care relating to an individual, including public safety health and medical related information that may affect public safety; an access control unit that controls the disclosure of the health and medical related information stored in the health and medical related information storage unit to a third party via a network; and a disclosure permission information storage unit that stores disclosure permission information indicating whether an individual permits disclosure of his or her own health and medical related information to a third party. The health and medical related information storage unit may store electronic medical record information, various test information, prescription information, medical history information, medication status information, vital information, interview information, etc., relating to an individual. the access control unit may store health and medical related information consisting of one or more of public safety health and medical related information, information on a public ballot, data from a health promotion app, conversation data on an interactive health promotion SNS, and public safety health and medical related information, and when the disclosure permission information held in the disclosure permission information holding unit indicates permission for disclosure, allows a third party to view the health and medical related information stored in the health and medical related information storage unit, excluding the public safety health and medical related information, and when the disclosure permission information held in the disclosure permission information holding unit is changed to refusal of disclosure, stops the third party from viewing the health and medical related information stored in the health and medical related information storage unit, excluding the public safety health and medical related information. Also, for example, the system may be one that accumulates health and medical information on an individual and discloses the health and medical information to a third party (medical worker or non-medical worker) based on the individual's consent. In this case, if the third party is a medical worker, the health and medical information may be disclosed as is, and if the third party is a non-medical worker, anonymized health and medical information may be disclosed. Furthermore, based on the individual's consent, each piece of health and medical information may be selected and disclosed to the third party, or all the health and medical information may be disclosed to the third party. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0068] <Description of the configuration of embodiment 1: Current prescription date information acquisition unit> The "current prescription date information acquisition unit" 305 is configured to have a function of acquiring current prescription date information, which is information indicating the prescription date of the drug identified by the current drug identification information for the drug recipient identified by the drug recipient identification information and is associated with the drug identification information of the drug that has been provided. Here, the "current prescription date information" may be acquired from the drug delivery history information stored in the drug delivery history information storage unit described above, or may be acquired via an API from a "healthcare information sharing system" (including, for example, a PHR system, etc.) or the like. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0069] <Description of the configuration of embodiment 1: Medication period information acquisition unit> The "medication period information acquisition unit" 306 is configured to have a function of acquiring, from the pharmaceutical delivery history information, medication period information, which is information for indicating a period during which a pharmaceutical that should theoretically be taken exists, from the previous prescription date to the current prescription date in association with pharmaceutical identification information that identifies the delivered pharmaceutical, from the pharmaceutical delivery history information. Here, the "medication period information" may be acquired from the pharmaceutical delivery history information stored in the pharmaceutical delivery history information storage unit described above, or may be acquired via an API from a "healthcare information sharing system" (including, for example, a PHR system, etc.) or the like. Here, the "last prescription date" refers to the day after the date on which the previously prescribed drug is expected to be properly consumed. In addition, "medication period information" refers to the period during which the drug can be consumed if the drug is taken correctly according to the dosage and administration instructions. For example, in the case of a 14-day prescription, the drug-taking period information is 14 days. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0070] <Description of the configuration of embodiment 1: Medication period information storage unit> The 'medication period information storage unit' 307 is configured to have a function of storing the medication period information acquired by the above-mentioned medication period information acquisition unit in association with the medication identification information. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0071] <Description of the configuration of embodiment 1: blank period information acquisition unit> The "blank period information acquisition unit" 308 is configured to have a function of acquiring blank period information, which is information for indicating a period from the previous prescription date to the current prescription date during which theoretically there is no drug to be taken, from the pharmaceutical delivery history information in association with drug identification information that identifies the drug to be delivered. Here, the "blank period information" is expressed as the number of days that have passed since the drug was prescribed (the number of days the drug cannot actually be taken). For example, if the number of days that have passed since a 14-day prescription was 4 days, the blank period information is 4 days. Here, "blank period information" includes not only information indicating periods during which medication was not actually taken, but also cases in which there is no blank period in taking medication. "No blank period" means blank period = 0 days. In some cases, the information may be designed to include information indicating periods in which medication is provided overlappingly, such as when the next medication is prescribed while there is still medication remaining. For example, the information may be designed to include information such as overlap period = minus 3 days. In this case, for example, information such as a large amount of sleeping pills in the patient's possession can be obtained, making it possible to detect the risk of mis-dosing. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included. In addition, the "blank period information" may be obtained from the pharmaceutical benefit history information stored in the pharmaceutical benefit history information storage unit described above, or may be obtained via an API from a "health and medical information sharing system" (including, for example, a PHR system, etc.).

[0072] <Description of the configuration of embodiment 1: blank period information storage unit> The 'blank period information storage unit' 309 is configured to have a function of storing blank period information acquired by the blank period information acquisition unit described above in association with medication identification information. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0073] <Description of the configuration of the first embodiment: Compliance rate calculation rule storage unit> The "compliance rate calculation rule storage unit" 310 is configured to have the function of storing, in association with drug identification information, compliance rate calculation rules, which are rules for calculating a compliance rate indicating that a drug user is taking the target drug in compliance with the dosage and administration instructions, based on medication period information and blank period information. 27 is a diagram showing an example of the compliance rate calculation rule (1) in the present invention. As shown in this figure, the compliance rate (%) is expressed as a numerical value obtained by dividing the medication period (days) by (medication period (days) + blank period (days)) and multiplying the result by 100. Here, since the compliance rate may not be divisible, it is expressed as a numerical value rounded off to one decimal place. Similarly, Fig. 28 is a diagram showing an example of compliance rate calculation rule (2) in the present invention. As shown in this figure, the compliance rate (%) is expressed as a numerical value obtained by dividing (medication period (days) - blank period (days)) by the medication period (days) and multiplying the result by 100. Here, since the compliance rate may not be divisible, it is expressed as a numerical value rounded off to one decimal place. Similarly, Fig. 29 is a diagram showing an example of the compliance rate calculation rule (3) in the present invention. As shown in this figure, the compliance rate (%) is expressed as a numerical value obtained by dividing (medication period (days) - blank period (days)) by (medication period (days) + blank period (days)) and multiplying the result by 100. Here, since the compliance rate may not be divisible, it is expressed as a numerical value rounded off to one decimal place. In this way, there are several possible patterns of compliance rate calculation rules, but in this specification, the case of compliance rate calculation rule (1) will be mainly described. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0074] <Description of the configuration of embodiment 1: compliance rate calculation unit> The "compliance rate calculation unit" 311 is configured to have the function of calculating the compliance rate for each drug for each drug recipient based on the drug recipient identification information, drug identification information, drug taking period information, blank period information, and compliance rate calculation rules. As can be seen from the compliance rate calculation rules (formula for calculating compliance rate) shown in Figure 27, the smaller the gap period (number of days) relative to the medication period (number of days), the higher the compliance rate (%); conversely, the larger the gap period (number of days) relative to the medication period (number of days), the lower the compliance rate (%). In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0075] <Description of the configuration of the first embodiment: Compliance rate storage unit> The "compliance rate storage unit" 312 is configured to have a function of storing the compliance rate calculated by the compliance rate calculation unit described above in association with the drug identification information. The stored compliance rate is used when deriving risk information, which will be described later. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0076] <Embodiment 1: Risk Assessment System: Hardware Configuration> The hardware configuration of the risk assessment system in this embodiment will be described with reference to the drawings.

[0077] Fig. 4 is a diagram showing the hardware configuration of the risk assessment system in this embodiment. As shown in this figure, the risk assessment system in this embodiment is equipped with a "CPU (Central Processing Unit)" 401 that performs various calculation processes, and a "main memory" 402. It also has a "non-volatile memory" 403 that stores predetermined information, and a "network I / F (interface)" 404 that transmits and receives information to and from multiple drug recipient terminals 406 and medical staff terminals 407. These are then connected to each other by a data communication path such as a "bus" 405, and perform the transmission and reception of information and processing.

[0078] Here, the "main memory" reads out programs that perform various processes to make the "CPU" execute them, and at the same time provides a work area that is also a work area for the programs. In addition, a plurality of addresses are assigned to each of the "main memory" and the "non-volatile memory", and the programs executed by the "CPU" can exchange data with each other and perform processing by identifying and accessing the addresses. In this embodiment, the programs stored in the "main memory" are a drug recipient identification information storage program, a drug identification information storage program, a drug delivery history information storage program, a previous prescription date information acquisition program, a current prescription date information acquisition program, a drug-taking period information acquisition program, a drug-taking period information storage program, a blank period information acquisition program, a blank period information storage program, a compliance rate calculation rule storage program, a compliance rate calculation program, and a compliance rate storage program. In addition, the "main memory" and the "non-volatile memory" store drug recipient identification information, drug identification information, drug delivery history information, previous prescription date information, current prescription date information, drug-taking period information, blank period information, compliance rate calculation rule, and compliance rate.

[0079] The "CPU" executes a medication recipient identification information retention program stored in the "main memory" to store the medication recipient identification information sent from the medical staff terminal through the "network I / F" in the "main memory" or "non-volatile memory". Also, it executes a medication identification information retention program stored in the "main memory" to store the medication identification information sent from the medical staff terminal through the "network I / F" in the "main memory" or "non-volatile memory". Also, it executes a pharmaceutical delivery history information retention program stored in the "main memory" to store the pharmaceutical delivery history information in the "main memory" or "non-volatile memory". Also, it executes a previous prescription date information acquisition program stored in the "main memory" to acquire previous prescription date information from the pharmaceutical delivery history information and store the previous prescription date information in the "main memory" or "non-volatile memory". Also, it executes a current prescription date information acquisition program stored in the "main memory" to acquire current prescription date information from the pharmaceutical delivery history information and store the current prescription date information in the "main memory" or "non-volatile memory". Also, it executes a medication period information acquisition program stored in the "main memory" to acquire medication period information from the pharmaceutical delivery history information. In addition, the medication period information retention program stored in the "main memory" is executed to store the acquired medication period information in the "main memory" or the "non-volatile memory". In addition, the blank period information acquisition program stored in the "main memory" is executed to acquire blank period information from pharmaceutical delivery history information. In addition, the blank period information retention program stored in the "main memory" is executed to store the acquired blank period information in the "main memory" or the "non-volatile memory". In addition, the compliance rate calculation rule retention program stored in the "main memory" is executed to store the compliance rate calculation rules in the "main memory" or the "non-volatile memory". In addition, the compliance rate calculation program stored in the "main memory" is executed to calculate the compliance rate based on the compliance rate calculation rules, etc. In addition, the compliance rate retention program stored in the "main memory" is executed to store the calculated compliance rate in the "main memory" or the "non-volatile memory".

[0080] <Embodiment 1: Risk assessment system: processing flow> 5 is a diagram showing a process flow when the risk determination system in this embodiment is used. As shown in the figure, the process includes steps S501, S502, S503, S504, S505, S506, S507, S508, S509, S510, S511, S512, S512, S511, S512, S513, S514, S515, S516, S517, S518, S519, S520, S521, S522, S523, S524, S525, S526, S527, S528, S529, S530, S531, S532, S533, S534, S535, S536, S537, S538, S539, S540, S541, S542, S543, S544, S545, S546, S547, S548, S549, S550, S5510, S5511, S5528, S5539, S5548, S5550, S5551, S5552, S5553, S5554, S5555, S556, S557, S558, S559, S550, S550, S550, S550, S550, S5510, S5511, S5512, S5510, S5510, S5511, S5512, S5512, S5513, S5555, S556, S557, S558, S559, S550, S550, S550, S550, S550, These processing methods include a patient identification information storage unit that stores patient identification information, which is information for uniquely identifying a patient who takes a drug indicated in information related to drug provision; a drug identification information storage unit that stores drug identification information, which is information for uniquely identifying a drug indicated in information related to drug provision; a drug provision history information storage unit that stores history information of information related to drug provision including drug identification information for a patient identified by the patient identification information stored in the patient identification information storage unit; a previous prescription date information acquisition unit that acquires previous prescription date information indicating the prescription date of a drug identified by the previous drug identification information for a patient identified by the patient identification information, which is associated with the drug identification information of a provided drug; a current prescription date information acquisition unit that acquires current prescription date information indicating the prescription date of a drug identified by the current drug identification information for a patient identified by the patient identification information, which is associated with the drug identification information of a provided drug; a medication period information acquisition unit that acquires medication period information from pharmaceutical delivery history information, a medication period information storage unit that stores the medication period information acquired by the medication period information acquisition unit in association with medication identification information, a blank period information acquisition unit that acquires blank period information from pharmaceutical delivery history information in association with medication identification information that identifies a medication to be delivered, the blank period information being information representing a period from a previous prescription date to a current prescription date during which no medication that should be taken is theoretically present, a blank period information storage unit that stores the blank period information acquired by the blank period information acquisition unit in association with medication identification information, and a compliance rate calculation rule holding unit that holds, in association with drug identification information, compliance rate calculation rules, which are rules for calculating a compliance rate indicating that the drug recipient is taking the target drug in compliance with the dosage and administration instructions, based on the drug recipient identification information and blank period information; a compliance rate calculation unit that calculates a compliance rate for each drug for each drug recipient, based on the drug recipient identification information, drug identification information, drug taking period information, blank period information, and the compliance rate calculation rules; and a compliance rate holding unit that holds the compliance rates calculated by the compliance rate calculation unit in association with the drug identification information.

[0081] The "medicine recipient identification information storage step" S501 is a step of storing the medicine recipient identification information, which is information for uniquely identifying the medicine recipient who takes the medicine indicated in the information related to the provision of medicines.

[0082] The "medicine identification information storage step" S502 is a stage for storing medicine identification information, which is information for uniquely identifying a medicine indicated in information related to the provision of medicines.

[0083] The "pharmaceutical delivery history information storage step" S503 is a step of storing history information on information related to the delivery of pharmaceuticals, including pharmaceutical identification information, for a pharmaceutical recipient identified by the stored pharmaceutical recipient identification information.

[0084] The "previous prescription date information acquisition step" S504 is a step for acquiring previous prescription date information associated with the drug identification information of the dispensed drug, which is information indicating the prescription date of the drug identified by the previous drug identification information of the drug recipient identified by the drug recipient identification information.

[0085] The "current prescription date information acquisition step" S505 is a step in which current prescription date information is acquired, which is information indicating the prescription date of the drug identified by the current drug identification information for the drug recipient identified by the drug recipient identification information, and is associated with the drug identification information of the drug provided.

[0086] The "medication period information acquisition step" S506 is a step in which medication period information, which is information representing the period from the previous prescription date to the current prescription date and indicating the period during which the drug that should theoretically be taken exists, is acquired from the pharmaceutical delivery history information in association with the drug identification information that identifies the drug to be provided.

[0087] The "medication period information storage step" S507 is a step of storing the acquired medication period information in association with the medication identification information.

[0088] The "blank period information acquisition step" S508 is a step in which blank period information, which is information representing the period from the previous prescription date to the current prescription date when there is theoretically no drug that should be taken, is acquired from the pharmaceutical delivery history information in association with drug identification information that identifies the drug to be delivered.

[0089] The "blank period information storage step" S509 is a stage for storing the acquired blank period information in association with the medicine identifying information.

[0090] The "compliance rate calculation rule storage step" S510 is a step in which compliance rate calculation rules, which are rules for calculating a compliance rate indicating that the user is taking the target drug in compliance with the dosage and administration instructions, based on medication period information and blank period information, are stored in association with drug identification information.

[0091] The "compliance rate calculation step" S511 is a step of calculating a compliance rate for each drug for each drug recipient based on the drug recipient identification information, drug identification information, drug-taking period information, blank period information, and compliance rate calculation rules.

[0092] The "compliance rate storage step" S512 is a step of storing the calculated compliance rate in association with the medicine identifying information.

[0093] <Summary> As described above, the present invention provides a risk assessment system that can calculate compliance rates for each drug for each drug recipient based on drug recipient identification information, drug identification information, drug taking period information, blank period information, and compliance rate calculation rules, and can store the compliance rates in association with the drug identification information.

[0094] <Embodiment 2 (corresponding mainly to claims 2, 11, and 20)> <Overview of the second embodiment> This embodiment provides a risk determination system having a statistical processing unit that statistically processes the retained compliance rate for each drug identification information, a statistical processing result storage unit that stores the statistical processing results, and a statistical processing result output unit that outputs the retained statistical processing results, based on the first embodiment. In order to realize this, a method executed by a CPU in the risk determination system, which is a computer, and an operating program for the risk determination system, which is written so as to be readable and executable by the risk determination system, which is a calculator, are also provided. Hereafter, explanations of functions, hardware configurations, and processing flows that overlap with those of the first embodiment will be omitted where appropriate.

[0095] <Functional configuration of embodiment 2> 6 is a diagram showing the functional configuration of a risk determination system in embodiment 2. In this embodiment, the risk determination system includes a statistical processing unit, a statistical processing result storage unit, and a statistical processing result output unit.

[0096] <Description of the configuration of the second embodiment: statistical processing unit> The 'statistical processing unit' 601 is configured to have a function of performing statistical processing of the retained compliance rate for each piece of medicine identifying information. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included. FIG. 30 is a diagram showing an example of the relationship between drug users, drugs, and compliance rates. As shown in this figure, there are three drug users taking drug A (drug identification information: P001), and drug user X1 has a compliance rate of 100%, drug user X5 has a compliance rate of 100%, and drug user X6 has a compliance rate of 87.5%. By averaging these, the average compliance rate for drug A (drug identification information: P001) is 95.8%. Similarly, there are three drug users for drug B (drug identification information: P002), and the average compliance rate is 90.0%. Similarly, there are three drug users for drug C (drug identification information: P003), and the average compliance rate is 84.1%. Similarly, there are three drug users for drug D (drug identification information: P004), and the average compliance rate is 75.4%. Similarly, there are three drug users for drug E (drug identification information P005), and the average compliance rate is 81.2%. Similarly, there are three patients taking drug F (drug identification information: P006), and the average compliance rate is 87.1%.

[0097] In this example, the statistical processing is performed by drug, but the present invention is not limited to this. For example, the statistical processing may be performed by drug category (prescription drugs, prescription drugs, over-the-counter drugs, etc.), by efficacy (antihypertensive drugs, diuretics, etc.), by identification code (part of code information that indicates attributes linked to drugs, etc.), by medical institution, by doctor, by age, etc.

[0098] In addition to the above, artificial intelligence may be used to learn various types of health and medical information that have been accumulated in advance in a "health and medical information sharing system" or the like, and then statistical processing may be performed by drug category, efficacy, identification code, medical institution, doctor, and age.

[0099] Here, "health and medical information" refers to an individual's electronic medical record information, various test information (which may include health checkups, medical examinations, etc.), prescription information, medication history information, medication status information, vital signs information (e.g., including at least, but not limited to, body temperature, blood pressure, pulse, heart rate, height, weight, blood glucose level, body fat percentage, arterial blood oxygen saturation, electroencephalogram, electrocardiogram, number of steps, respiratory rate, heart sounds, urine measurement information (e.g., urinary sugar, urinary protein, urinary occult blood, urobilinogen, pH, bilirubin, ketone bodies, nitrites, etc.), sleep time, etc.), information from medical questionnaires, data from health promotion apps, conversation data from interactive health promotion SNS, etc.

[0100] In addition, the "electronic medical record information" may include, for example, basic information about the patient (e.g., patient ID, name, date of birth, contact information, emergency contact information, family history, height and weight, allergy information, smoking and drinking status, medical history, etc.), information about the examination (e.g., the patient's main complaint (subjective symptoms and complaints about physical condition, etc.), various test results, medication information, diagnosis, treatment plan, doctor's examination record, doctor's instructions, etc.), information about nursing and progress (e.g., vital signs information (e.g., body temperature, blood pressure, pulse, heart rate, height, weight, blood glucose level, body fat percentage, arterial blood oxygen saturation, brain wave, electrocardiogram, number of steps, respiratory rate, heart sound, urine measurement information (e.g., urinary sugar, urinary protein, urinary occult blood, uro It may also include, but is not limited to, bilinogen, pH, bilirubin, ketone bodies, nitrites, etc.), sleep time, etc.), observation results, records of urine and stool, records of food content and intake, records of nursing care, etc.), information regarding tests (e.g., test instructions, test results, images (partially) obtained from imaging tests, reports on those images, etc.), information regarding treatment or surgery (e.g., instructions for treatment or surgery, progress and results of treatment or surgery, method and diagnosis if a pathological diagnosis was performed, etc.), information regarding medication (e.g., medication instructions, date and time of medication and medication, results of medication, etc.), and follow-up information after treatment or surgery.

[0101] In addition, "prescription information" may include, for example, the insurer number, name, date of birth, sex, name of the medical institution, contact information, name of the prescribing doctor, name of the medication, form of the medication (tablet, capsule, liquid, powder, granule, etc.), amount of medication (amount to take per dose), number of times to take per day, timing of taking, information about changing to generic drugs, number of times of divided dispensing, etc.

[0102] In addition, "medicinal history information" may include, for example, the patient's name, date of birth, sex, insured person's card number, address, emergency contact information, name of the prescribed medical institution and name of the insured physician, prescription date, prescription contents, dispensing date, key points of inquiries regarding the prescription contents, the patient's constitution, allergy history, side effect history, key points of inquiries from the patient or their family, medication status, confirmation of remaining medication status, changes in physical condition while taking the medication, concomitant medications, medical history information including complications, whether the patient has visited another department, whether or not there are symptoms that are suspected to be side effects, food and drink intake (drug interactions), the patient's wishes regarding the use of generic drugs, the status of information provided in the notebook, key points of medication instructions, name of the insured pharmacist who provided instructions, and medication status information.

[0103] In addition, "medication status information" may include, for example, information regarding the remaining amount of prescribed medication (including, for example, the amount of medication remaining if the patient accidentally forgets to take the medication or if the patient intentionally does not take the medication), timing information regarding visits to the hospital / clinic (for example, the period from the scheduled end date of the prescription (scheduled end date of medication) to the actual visit to the hospital / clinic (including, for example, a visit to the hospital / clinic earlier than scheduled or later than scheduled)), and patient complaints about medication (including subjective symptoms and complaints about physical condition, such as developing hives after taking a certain medication continuously, or feeling dizzy after taking a certain medication because it was too effective).

[0104] <Description of the configuration of the second embodiment: Statistical processing result storage unit> The 'statistical processing result storage unit' 602 is configured to have a function of storing the results of the statistical processing performed by the above-mentioned statistical processing unit. For example, as shown in Figure 30, it is preferable to keep together information that pharmaceutical manufacturer Y manufactures and sells drugs A, B, and C, that pharmaceutical manufacturer Z manufactures and sells drugs D, E, and F, and what the average compliance rate results for each drug are.

[0105] <Description of the configuration of the second embodiment: Statistical processing result output unit> The 'statistical processing result output unit' 603 is configured to have a function of outputting the held statistical processing results. For example, as shown in FIG. 30, it is possible to report the average compliance rates of drugs A, B, and C to drug manufacturer Y, and the average compliance rates of drugs D, E, and F to drug manufacturer Z. This allows drug manufacturers to know the extent to which their drugs are being taken with compliance. Receiving such feedback can lead to improvements in drugs and the development of new drugs. In addition, the statistical processing results may be output to "medical workers" or "non-medical workers" based on the consent of the patient. Here, "non-medical workers" refers to at least one of the following employees of life insurance companies, non-life insurance companies, securities companies, pharmaceutical companies, drug discovery venture companies, food companies, bedding companies, health equipment companies, fitness clubs, sports gyms, banks, credit unions, JA, health insurance associations, health insurance associations, mutual aid associations, municipal health insurance, national health insurance associations, PR companies, research institutes, universities and graduate schools (including affiliated research institutes), technical colleges, agriculture, forestry and fisheries companies, fertilizer companies, government agencies, local governments, and independent administrative agencies. The statistical processing results output by the statistical processing result output unit may be temporarily stored in the "healthcare information sharing system" and then sent from there to "medical professionals" or "non-medical professionals."

[0106] <Embodiment 2: Risk Assessment System: Hardware Configuration> The hardware configuration of the risk assessment system in this embodiment will be described with reference to the drawings.

[0107] Fig. 7 is a diagram showing the hardware configuration of the risk assessment system in this embodiment. As shown in this figure, the risk assessment system in this embodiment is equipped with a "CPU (Central Processing Unit)" 701 that performs various calculation processes, and a "main memory" 702. It also has a "non-volatile memory" 703 that holds predetermined information, and a "network I / F (interface)" 704 that transmits and receives information to and from multiple drug recipient terminals 706 and medical staff terminals 707. These are then connected to each other by a data communication path such as a "bus" 705, and perform the transmission and reception of information and processing.

[0108] Here, the "main memory" reads out programs that perform various processes to be executed by the "CPU", and also provides a work area that is a working area for the programs. In addition, multiple addresses are assigned to this "main memory" and "non-volatile memory", and the programs executed by the "CPU" can exchange data with each other and perform processing by identifying and accessing these addresses. In this embodiment, the programs stored in the "main memory" include a statistical processing program, a statistical processing result storage program, and a statistical processing result output program. In addition, the "main memory" and "non-volatile memory" store drug identification information, compliance rate, statistical processing result information, etc.

[0109] The "CPU" executes the statistical processing program stored in the "main memory" and performs statistical processing of the retained compliance rate for each drug identification information via the "network I / F". It also executes the statistical processing result retention program stored in the "main memory" and stores the drug identification information and the average compliance rate for each drug (statistical processing result information) in the "main memory" and "non-volatile memory". It also executes the statistical processing result output program stored in the "main memory" and outputs the statistical processing result information stored in the "main memory" and "non-volatile memory" to outside the system via the "network I / F".

[0110] <Embodiment 2: Risk assessment system: processing flow> 8 is a diagram showing a process flow when the risk determination system in this embodiment is used. As shown in the diagram, the processing method includes a statistical processing step S801, a statistical processing result storage step S802, and a statistical processing result output step S803. These processing methods are executed by a risk assessment system having a statistical processing unit that performs statistical processing of the retained compliance rate for each drug identification information, a statistical processing result storage unit that stores the statistical processing results, and a statistical processing result output unit that outputs the retained statistical processing results.

[0111] The "statistical processing step" S801 is a stage in which the retained compliance rate is statistically processed for each piece of medicine identifying information.

[0112] The "statistical processing result storage step" S802 is a stage for storing the statistical processing results.

[0113] The "statistical processing result output step" S803 is a step for outputting the held statistical processing results.

[0114] <Summary> As described above, the present invention can provide a risk assessment system that is capable of statistically processing the retained compliance rate for each drug identification information, retaining the results of the statistical processing, and outputting the retained statistical processing results.

[0115] <Embodiment 3 (corresponding mainly to claims 3, 12, and 21)> <Overview of the Third Embodiment> This embodiment provides a risk determination system that calculates compliance rates for each drug for each drug recipient based on drug recipient identification information, drug identification information, drug-taking period information, blank period information, and compliance rate calculation rules, and stores the compliance rates in association with the drug identification information, based on the first and second embodiments. In order to achieve this, a method executed by a CPU in the risk determination system, which is a computer, and an operating program for the risk determination system, which is written so as to be readable and executable by the risk determination system, which is a calculator, are provided. Hereafter, explanations of functions, hardware configurations, and processing flows that overlap with those of the first and second embodiments will be omitted where appropriate.

[0116] <Functional configuration of embodiment 3> 9 is a diagram showing the functional configuration of the risk assessment system in embodiment 3. In this embodiment, the system includes a medication user identification information storage unit, a medication identification information storage unit, a pharmaceutical delivery history information storage unit, a current prescription date information acquisition unit, a past prescription date information acquisition unit, a medication period information acquisition unit, a medication period information storage unit, a blank period information acquisition unit, a blank period information storage unit, a compliance rate calculation rule storage unit, a compliance rate calculation unit, and a compliance rate storage unit.

[0117] <Embodiment 3: Configuration of Drug User Identification Information Storage Unit> The "medicine recipient identification information storage unit" 901 is configured to have a function of storing the medicine recipient identification information, which is information for uniquely identifying the medicine recipient who takes the medicine indicated in the information related to the provision of medicine. The function is the same as that of the "medicine recipient identification information storage unit" in the first embodiment.

[0118] <Embodiment 3: Description of the configuration: Drug identification information storage unit> The "medicine identification information storage unit" 902 is configured to have a function of storing medicine identification information, which is information for uniquely identifying a medicine indicated in information related to the provision of medicine. The function is the same as that of the "medicine identification information storage unit" in the first embodiment.

[0119] <Configuration of the third embodiment: Drug delivery history information storage unit> The "pharmaceutical delivery history information storage unit" 903 is configured to have a function of storing history information on the delivery of pharmaceuticals, including pharmaceutical identification information, for a pharmaceutical recipient identified by the stored pharmaceutical recipient identification information. This function is the same as that of the "pharmaceutical delivery history information storage unit" in the first embodiment.

[0120] <Configuration of the Third Embodiment: Current Prescription Date Information Acquisition Unit> The "previous prescription date information acquisition unit" 904 is configured to have a function of acquiring current prescription date information associated with the drug identification information of the dispensed drug, which is information indicating the prescription date of the drug identified by the current drug identification information of the drug recipient identified by the drug recipient identification information. This function is the same as that of the "current prescription date information acquisition unit" in the first embodiment.

[0121] <Configuration of the Third Embodiment: Past Prescription Date Information Acquisition Unit> The "past prescription date information acquisition unit" 905 is configured to have a function of acquiring past prescription date information associated with the drug identification information of a dispensed drug, which is information indicating the prescription date of a drug identified by the past drug identification information of a drug dispenser identified by the drug dispenser identification information. Here, the "past prescription date information" may be acquired from the drug payment history information stored in the drug payment history information storage unit described above, or may be acquired via an API from a "healthcare information sharing system" (including, for example, a PHR system). The past prescription date information is information indicating a prescription date at a certain point in time going back in time, and may be arbitrarily designated as information indicating, for example, the prescription date three times back or the prescription date ten times back. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0122] <Configuration of the third embodiment: Medication period information acquisition unit> The "medication period information acquisition unit" 906 is configured to have a function of acquiring, from the pharmaceutical delivery history information, medication period information, which is information for indicating a period during which a pharmaceutical that should theoretically be taken exists, from a previous prescription date to a current prescription date in association with pharmaceutical identification information that identifies the pharmaceutical to be delivered. Here, the "medication period information" may be acquired from the pharmaceutical delivery history information stored in the pharmaceutical delivery history information storage unit described above, or may be acquired via an API from a "healthcare information sharing system" (including, for example, a PHR system, etc.) or the like. In addition, the "previous prescription date" refers to the day after the date on which the previously prescribed drug is expected to be properly consumed. In addition, "medication period information" refers to the period during which the drug can be consumed if it is assumed that the drug is taken correctly according to the dosage and administration instructions. For example, if a 14-day prescription is repeated three times, the medication period information will be a total of 42 days. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0123] <Configuration of the third embodiment: Medication period information storage unit> The 'medication period information storage unit' 907 is configured to have a function of storing the medication period information acquired by the above-mentioned medication period information acquisition unit in association with the medication identification information. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0124] <Embodiment 3: Configuration of Blank Period Information Acquisition Unit> The "blank period information acquisition unit" 908 is configured to have a function of acquiring blank period information, which is information for indicating a period from a previous prescription date to a current prescription date in association with drug identification information that identifies a drug to be delivered, from the drug delivery history information, during which no drug that should be taken is theoretically present. Here, the "blank period information" may be acquired from the drug delivery history information stored in the drug delivery history information storage unit described above, or may be acquired via an API from a "healthcare information sharing system" (including, for example, a PHR system). The "blank period information" is expressed as the number of days that have passed since the drug was prescribed (the number of days that the drug cannot actually be taken). For example, if a 14-day prescription is repeated three times and the number of days that have passed is a total of 12 days, the blank period information is 12 days. Furthermore, in addition to information indicating periods during which medication was not actually taken, "blank period information" also includes cases where there is no blank period in taking medication. "No blank period" means blank period = 0 days. In some cases, the information may be designed to include information indicating periods when medication is provided in duplicate, such as when the next medication is prescribed when there is still medication remaining. For example, the information may be designed to include information such as overlapping period = minus 3 days. In this case, for example, information such as a large amount of sleeping pills on hand by the user can be known, making it possible to detect the risk of mis-dosing. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0125] <Embodiment 3: Description of Configuration: Blank Period Information Storage Unit> The 'blank period information storage unit' 909 is configured to have a function of storing blank period information acquired by the blank period information acquisition unit described above in association with medication identification information. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0126] <Embodiment 3: Description of Configuration: Compliance Rate Calculation Rule Storage Unit> The "compliance rate calculation rule storage unit" 910 is configured to have the function of storing, in association with drug identification information, compliance rate calculation rules, which are rules for calculating a compliance rate indicating that a drug user is taking the target drug in compliance with the dosage and administration instructions, based on medication period information and blank period information. 27 is a diagram showing an example of the compliance rate calculation rule (1) in the present invention. As shown in this figure, the compliance rate (%) is expressed as a numerical value obtained by dividing the medication period (days) by (medication period (days) + blank period (days)) and multiplying the result by 100. Here, since the compliance rate may not be divisible, it is expressed as a numerical value rounded off to one decimal place. Similarly, Fig. 28 is a diagram showing an example of compliance rate calculation rule (2) in the present invention. As shown in this figure, the compliance rate (%) is expressed as a numerical value obtained by dividing (medication period (days) - blank period (days)) by the medication period (days) and multiplying the result by 100. Here, since the compliance rate may not be divisible, it is expressed as a numerical value rounded off to one decimal place. Similarly, Fig. 29 is a diagram showing an example of the compliance rate calculation rule (3) in the present invention. As shown in this figure, the compliance rate (%) is expressed as a numerical value obtained by dividing (medication period (days) - blank period (days)) by (medication period (days) + blank period (days)) and multiplying the result by 100. Here, since the compliance rate may not be divisible, it is expressed as a numerical value rounded off to one decimal place. In this way, there are several possible patterns of compliance rate calculation rules, but in this specification, the case of compliance rate calculation rule (1) will be mainly described. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0127] <Embodiment 3: Description of Configuration: Compliance Rate Calculation Unit> The 'compliance rate calculation unit' 911 is configured to have a function of calculating a compliance rate for each drug for each drug recipient based on the drug recipient identification information, drug identification information, drug taking period information, blank period information, and compliance rate calculation rules. As can be seen from the compliance rate calculation rules (formula for calculating compliance rate) shown in Figure 27, the smaller the gap period (number of days) relative to the medication period (number of days), the higher the compliance rate (%). Conversely, there is a tendency that the larger the gap period (number of days) relative to the medication period (number of days), the lower the compliance rate (%). In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0128] <Embodiment 3: Description of Configuration: Compliance Rate Storage Unit> The "compliance rate storage unit" 912 is configured to have a function of storing the compliance rate calculated by the compliance rate calculation unit described above in association with the drug identification information. The stored compliance rate is used when deriving risk information, which will be described later. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0129] <Embodiment 3: Risk Assessment System: Hardware Configuration> The hardware configuration of the risk assessment system in this embodiment will be described with reference to the drawings.

[0130] Fig. 10 is a diagram showing the hardware configuration of the risk assessment system in this embodiment. As shown in this figure, the risk assessment system in this embodiment includes a "CPU (Central Processing Unit)" 1001 that performs various calculation processes, and a "main memory" 1002. It also includes a "non-volatile memory" 1003 that stores predetermined information, and a "network I / F (interface)" 1004 that transmits and receives information to and from multiple drug recipient terminals 1006 and medical staff terminals 1007. These are then connected to each other by a data communication path such as a "bus" 1005, and perform the transmission and reception of information and processing.

[0131] Here, the "main memory" reads out programs that perform various processes to make the "CPU" execute them, and at the same time provides a work area that is also a work area for the programs. In addition, a plurality of addresses are assigned to each of the "main memory" and the "non-volatile memory", and the programs executed by the "CPU" can exchange data with each other and perform processing by identifying and accessing the addresses. In this embodiment, the programs stored in the "main memory" are a drug recipient identification information holding program, a drug identification information holding program, a drug delivery history information holding program, a current prescription date information acquisition program, a past prescription date information acquisition program, a drug-taking period information acquisition program, a drug-taking period information holding program, a blank period information acquisition program, a blank period information holding program, a compliance rate calculation rule holding program, a compliance rate calculation program, and a compliance rate holding program. In addition, the "main memory" and the "non-volatile memory" store drug recipient identification information, drug identification information, drug delivery history information, current prescription date information, past prescription date information, drug-taking period information, blank period information, compliance rate calculation rule, and compliance rate.

[0132] The "CPU" executes a medication recipient identification information retention program stored in the "main memory" to store the medication recipient identification information sent from the medical staff terminal through the "network I / F" in the "main memory" or "non-volatile memory". Also, it executes a medication identification information retention program stored in the "main memory" to store the medication identification information sent from the medical staff terminal through the "network I / F" in the "main memory" or "non-volatile memory". Also, it executes a pharmaceutical delivery history information retention program stored in the "main memory" to store the pharmaceutical delivery history information in the "main memory" or "non-volatile memory". Also, it executes a current prescription date information acquisition program stored in the "main memory" to acquire current prescription date information from the pharmaceutical delivery history information and store the current prescription date information in the "main memory" or "non-volatile memory". Also, it executes a past prescription date information acquisition program stored in the "main memory" to acquire past prescription date information from the pharmaceutical delivery history information and store the past prescription date information in the "main memory" or "non-volatile memory". Also, it executes a medication period information acquisition program stored in the "main memory" to acquire medication period information from the pharmaceutical delivery history information. In addition, the medication period information retention program stored in the "main memory" is executed to store the acquired medication period information in the "main memory" or the "non-volatile memory". In addition, the blank period information acquisition program stored in the "main memory" is executed to acquire blank period information from pharmaceutical delivery history information. In addition, the blank period information retention program stored in the "main memory" is executed to store the acquired blank period information in the "main memory" or the "non-volatile memory". In addition, the compliance rate calculation rule retention program stored in the "main memory" is executed to store the compliance rate calculation rules in the "main memory" or the "non-volatile memory". In addition, the compliance rate calculation program stored in the "main memory" is executed to calculate the compliance rate based on the compliance rate calculation rules, etc. In addition, the compliance rate retention program stored in the "main memory" is executed to store the calculated compliance rate in the "main memory" or the "non-volatile memory".

[0133] <Embodiment 3: Risk assessment system: processing flow> Fig. 11 is a diagram showing a process flow when the risk determination system in this embodiment is used. As shown in the figure, the processing method includes a medication user identification information storage step S1101, a medication identification information storage step S1102, a pharmaceutical delivery history information storage step S1103, a current prescription date information acquisition step S1104, a past prescription date information acquisition step S1105, a medication period information acquisition step S1106, a medication period information storage step S1107, a blank period information acquisition step S1108, a blank period information storage step S1109, an adherence rate calculation rule storage step S1110, an adherence rate calculation step S1111, and an adherence rate storage step S1112. These processing methods include a patient identification information storage unit that stores patient identification information, which is information for uniquely identifying a patient who takes a drug indicated in information related to drug provision; a drug identification information storage unit that stores drug identification information, which is information for uniquely identifying a drug indicated in information related to drug provision; a drug provision history information storage unit that stores history information of information related to drug provision including drug identification information for a patient identified by the patient identification information stored in the patient identification information storage unit; a current prescription date information acquisition unit that acquires current prescription date information, which is information indicating the prescription date of a drug identified by the current drug identification information for a patient identified by the patient identification information, and which is associated with the drug identification information of a provided drug; a past prescription date information acquisition unit that acquires past prescription date information, which is information indicating the prescription date of a drug identified by past drug identification information for a patient identified by the patient identification information, and which is associated with the drug identification information of a provided drug; a medication period information acquisition unit that acquires medication period information from pharmaceutical delivery history information, a medication period information storage unit that stores the medication period information acquired by the medication period information acquisition unit in association with medication identification information, a blank period information acquisition unit that acquires blank period information from pharmaceutical delivery history information in association with medication identification information that identifies a medication to be delivered, the blank period information being information representing a period from a previous prescription date to a current prescription date during which no medication that should be taken is theoretically present, a blank period information storage unit that stores the blank period information acquired by the blank period information acquisition unit in association with medication identification information, and a compliance rate calculation rule holding unit that holds, in association with drug identification information, compliance rate calculation rules, which are rules for calculating a compliance rate indicating that the drug recipient is taking the target drug in compliance with the dosage and administration instructions, based on the drug recipient identification information and blank period information; a compliance rate calculation unit that calculates a compliance rate for each drug for each drug recipient, based on the drug recipient identification information, drug identification information, drug taking period information, blank period information, and the compliance rate calculation rules; and a compliance rate holding unit that holds the compliance rates calculated by the compliance rate calculation unit in association with the drug identification information.

[0134] The "medicine recipient identification information storage step" S1101 is a step of storing the medicine recipient identification information, which is information for uniquely identifying the medicine recipient who takes the medicine indicated in the information related to the provision of medicines.

[0135] The "medicine identification information storage step" S1102 is a step of storing medicine identification information, which is information for uniquely identifying a medicine indicated in information related to the provision of medicines.

[0136] The "pharmaceutical delivery history information storage step" S1103 is a step of storing history information on information related to the delivery of pharmaceuticals, including pharmaceutical identification information, for a pharmaceutical recipient identified by the stored pharmaceutical recipient identification information.

[0137] The "current prescription date information acquisition step" S1104 is a step in which current prescription date information is acquired, which is information indicating the prescription date of the drug identified by the current drug identification information for the drug recipient identified by the drug provider identification information and is associated with the drug identification information of the drug provided.

[0138] The "past prescription date information acquisition step" S1105 is a step for acquiring past prescription date information associated with the drug identification information of the dispensed drug, which is information indicating the prescription date of the drug identified by the past drug identification information of the drug recipient identified by the drug recipient identification information.

[0139] The "medication period information acquisition step" S1106 is a step in which medication period information, which is information representing the period from the previous prescription date to the current prescription date and indicating the period during which the drug that should theoretically be taken exists, is acquired from the pharmaceutical delivery history information in association with the drug identification information that identifies the drug to be provided.

[0140] The "medication period information storage step" S1107 is a step of storing the acquired medication period information in association with the medication identification information.

[0141] The "blank period information acquisition step" S1108 is a step in which blank period information, which is information representing the period from the previous prescription date to the current prescription date and during which no medication that should theoretically be taken exists, is acquired from the pharmaceutical delivery history information in association with the pharmaceutical identification information that identifies the medication to be delivered.

[0142] The "blank period information storage step" S1109 is a step of storing the acquired blank period information in association with the medicine identifying information.

[0143] The "compliance rate calculation rule storage step" S1110 is a step in which compliance rate calculation rules, which are rules for calculating a compliance rate indicating that the user is taking the target drug in compliance with the dosage and administration instructions, based on medication period information and blank period information, are stored in association with drug identification information.

[0144] The "compliance rate calculation step" S1111 is a stage in which a compliance rate is calculated for each drug for each drug recipient based on the drug recipient identification information, drug identification information, drug-taking period information, blank period information, and compliance rate calculation rules.

[0145] The "compliance rate storage step" S1112 is a step of storing the calculated compliance rate in association with the medicine identifying information.

[0146] <Summary> As described above, the present invention provides a risk assessment system that can calculate compliance rates for each drug for each drug recipient based on drug recipient identification information, drug identification information, drug taking period information, blank period information, and compliance rate calculation rules, and can store the compliance rates in association with the drug identification information.

[0147] <Embodiment 4 (corresponding mainly to claims 4, 13, and 22)> <Overview of embodiment 4> This embodiment provides a risk determination system having a statistical processing unit that statistically processes the retained compliance rate for each drug identification information, a statistical processing result storage unit that stores the statistical processing result, and a statistical processing result output unit that outputs the retained statistical processing result, based on the embodiments 1 to 3. In order to realize this, a method executed by a CPU in the risk determination system, which is a computer, and an operating program for the risk determination system, which is written so as to be readable and executable by the risk determination system, which is a calculator, are also provided. Hereinafter, explanations of functions, hardware configurations, and processing flows that overlap with those of the first to third embodiments will be omitted as appropriate.

[0148] <Functional Configuration of Fourth Embodiment> 12 is a diagram showing the functional configuration of a risk determination system in embodiment 4. In this embodiment, the risk determination system includes a statistical processing unit, a statistical processing result storage unit, and a statistical processing result output unit.

[0149] <Embodiment 4: Description of Configuration: Statistical Processing Unit> The "statistical processing unit" 1201 is configured to have a function of performing statistical processing of the retained compliance rate for each piece of medicine identifying information. This function is the same as that of the "statistical processing unit" in the second embodiment.

[0150] <Fourth embodiment: configuration: statistical processing result storage unit> The "statistical processing result storage unit" 1202 is configured to have a function of storing the results of statistical processing performed by the statistical processing unit described above. This function is the same as that of the "statistical processing result storage unit" in the second embodiment.

[0151] <Embodiment 4: Configuration Description: Statistical Processing Result Output Unit> The 'statistical processing result output unit' 1203 is configured to have a function of outputting the held statistical processing results. This function is the same as that of the 'statistical processing result output unit' in the second embodiment.

[0152] <Embodiment 4: Risk Assessment System: Hardware Configuration> The hardware configuration of the risk assessment system in this embodiment will be described with reference to the drawings.

[0153] Fig. 13 is a diagram showing the hardware configuration of the risk assessment system in this embodiment. As shown in this figure, the risk assessment system in this embodiment includes a "CPU (Central Processing Unit)" 1301 that performs various calculation processes, and a "main memory" 1302. It also includes a "non-volatile memory" 1303 that stores predetermined information, and a "network I / F (interface)" 1304 that transmits and receives information to and from multiple drug recipient terminals 1306 and medical staff terminals 1307. These are then connected to each other by a data communication path such as a "bus" 1305, and perform the transmission and reception of information and processing.

[0154] Here, the "main memory" reads out programs that perform various processes to be executed by the "CPU", and also provides a work area that is a working area for the programs. In addition, multiple addresses are assigned to this "main memory" and "non-volatile memory", and the programs executed by the "CPU" can exchange data with each other and perform processing by identifying and accessing these addresses. In this embodiment, the programs stored in the "main memory" include a statistical processing program, a statistical processing result storage program, and a statistical processing result output program. In addition, the "main memory" and "non-volatile memory" store drug identification information, compliance rate, statistical processing result information, etc.

[0155] The "CPU" executes the statistical processing program stored in the "main memory" and performs statistical processing of the retained compliance rate for each drug identification information via the "network I / F". It also executes the statistical processing result retention program stored in the "main memory" and stores the drug identification information and the average compliance rate for each drug (statistical processing result information) in the "main memory" and "non-volatile memory". It also executes the statistical processing result output program stored in the "main memory" and outputs the statistical processing result information stored in the "main memory" and "non-volatile memory" to outside the system via the "network I / F".

[0156] <Embodiment 4: Risk assessment system: processing flow> 14 is a diagram showing a process flow when the risk determination system in this embodiment is used. As shown in the diagram, the processing method includes a statistical processing step S1401, a statistical processing result storage step S1402, and a statistical processing result output step S1403. These processing methods are executed by a risk assessment system having a statistical processing unit that performs statistical processing of the retained compliance rate for each drug identification information, a statistical processing result storage unit that stores the statistical processing results, and a statistical processing result output unit that outputs the retained statistical processing results.

[0157] The "statistical processing step" S1401 is a stage in which the retained compliance rate is statistically processed for each piece of medicine identifying information.

[0158] The "statistical processing result storage step" S1402 is a stage for storing the statistical processing result.

[0159] The "statistical processing result output step" S1403 is a step for outputting the held statistical processing results.

[0160] <Summary> As described above, the present invention can provide a risk assessment system that is capable of statistically processing the retained compliance rate for each drug identification information, retaining the results of the statistical processing, and outputting the retained statistical processing results.

[0161] <Embodiment 5 (corresponding mainly to claims 5, 14, and 23)> <Outline of the fifth embodiment> This embodiment is characterized in that it includes a risk information derivation rule storage unit that stores risk information derivation rules, which are rules for deriving risk information representing the risk manifested by the medication behavior of a medication recipient identified by medication recipient identification information, based on the adherence rate stored, a medication recipient-specific drug-specific risk information determination unit that determines risk information for each medication recipient based on the medication recipient identification information, medication identification information, medication period information, blank period information, adherence rate calculation rule, and risk information derivation rule, and a risk information storage unit that associates and stores the determined risk information with the medication recipient identification information and the medication identification information. In order to achieve this, a method executed by a CPU in a risk determination system that is a computer, and an operating program of the risk determination system that is written so as to be readable and executable by the risk determination system that is a calculator are provided. Hereinafter, the functions, hardware configuration, and processing flow that overlap with those of the first to fourth embodiments will be omitted as appropriate.

[0162] <Functional configuration of embodiment 5> 15 is a diagram showing the functional configuration of the risk determination system in embodiment 5. In this embodiment, the system includes a risk information derivation rule storage unit, a patient-specific / drug-specific risk information determination unit, and a risk information storage unit.

[0163] <Fifth embodiment: Description of configuration: Risk information derivation rule storage unit> The "risk information derivation rule storage unit" 1501 is configured to have the function of storing risk information derivation rules, which are rules for deriving risk information representing the risks that arise from the medication behavior of a medication recipient identified by medication recipient identification information, based on the stored compliance rate. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. Here, there are at least three types of "risks arising from the medication-taking behavior of the medication user." In any case, the risk is determined by the relationship between the type of medication taken and the compliance rate for that medication. First, there is a risk of patients dropping out of taking the drug without consulting a medical professional. In such cases, patients may not adhere to the drug regimen properly, resulting in poor therapeutic outcomes. There is also the risk of leftover medication increasing, resulting in higher medical costs. Secondly, there is a risk of the illness worsening if the patient fails to follow the dosage and administration instructions for the drug. In such a case, for example, if a patient with hypertension takes a drug (antihypertensive drug) and his / her blood pressure temporarily drops, but then suddenly stops taking the drug, his / her blood pressure will rise again, and in the worst case scenario, he / she may suffer a cerebral hemorrhage. Thirdly, there is a risk of complications, where one disease leads to another, due to the patient's inability to take the drug in accordance with its dosage and administration instructions. In such cases, for example, if a diabetic patient continues to suffer from the disease for a long period of time, he or she may develop complications such as diabetic retinopathy (leading to blindness in the worst case), diabetic nephropathy (leading to dialysis in the worst case), and diabetic neuropathy (leading to amputation of the leg in the worst case). In the following description of the present application, the risk information will be explained by taking the "dropout risk" as an example. FIG. 31 is a diagram showing an example of risk information derivation rules (in the case of dropout risk) in the present invention. In this example, the dropout risk is derived in three stages depending on the range of the compliance rate (%). For example, in the case of (1), if the compliance rate (%) is greater than 90.0 and less than or equal to 100.0, the dropout risk A (good) is derived. In the case of (2), if the compliance rate (%) is greater than 70.0 and less than or equal to 90.0, the dropout risk B (caution) is derived. In the case of (3), if the compliance rate (%) is greater than 0.0 and less than or equal to 70.0, the dropout risk C (dangerous) is derived.

[0164] <Configuration of embodiment 5: Risk information determination unit for each patient and each drug> The “risk information determination unit for each drug and for each patient” 1502 is configured to have the function of determining risk information for each drug and for each patient based on the drug recipient identification information, drug identification information, drug-taking period information, blank period information, compliance rate calculation rules, and risk information derivation rules. In short, it is desirable to determine risk information from the relationship between the medication being taken (medication identification information), the compliance rate with that medication, and the recipient who takes that medication (recipient identification information). In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0165] 32 is a diagram showing an example (1) of the risk of falling off in the present invention. This corresponds to the case of embodiment 1. In FIG. 32, for example, there are recipient A (recipient identification information: A001) and recipient B (recipient identification information: A002). For example, patient A is taking three types of medication as shown in (1) to (3) below. In FIG. 1, medication BA (medication identification information: B001) is prescribed by hospital CA, which is a medical institution. In FIG. 2, medication BB (medication identification information: B002) is prescribed by clinic CB, which is a medical institution. In FIG. 3, medication BC (medication identification information: B003) is prescribed by clinic CC, which is a medical institution. Also, patient B is taking two types of medication, for example, as shown in (4) and (5) below. In (4) of the same figure, medication BB (medication identification information: B002) has been prescribed by clinic CB, which is a medical institution. In (5) of the same figure, medication BD (medication identification information: B004) has been prescribed by clinic CD, which is a medical institution. It should be noted that, for the sake of convenience, the dropout risk is judged assuming that the number of days for which a drug has been prescribed is 14 days and that all previous prescription dates are the same date. In reality, it is common for the prescription dates and number of days for which a drug has been prescribed to vary at each medical institution. More specifically, in the case of FIG. 21 (1), patient A (medication user identification information: A001) is prescribed drug BA (medication identification information: B001) by hospital CA, with a medication period of 14 days and a blank period of 2 days. When this medication period information and blank period information are used and applied to the compliance rate calculation rule of FIG. 21, the compliance rate is 87.5%, and when applied to the risk information derivation rule of FIG. 22, the risk information is determined as dropout risk B. Similarly, in the case of FIG. 21 (2), the compliance rate for drug BB (medication identification information: B002) is 100%, and the risk information is determined as dropout risk A. Similarly, in the case of FIG. 21 (3), the compliance rate for drug BC (medication identification information: B003) is 70.0%, and the risk information is determined as dropout risk C. Similarly, for patient B (medicine user identification information: A002), if we consider the case of (4) in the same figure, the compliance rate for drug BB (drug identification information: B002) will be 100%, and the risk information will be determined to be dropout risk A. Similarly, if we consider the case of (5) in the same figure, the compliance rate for drug BD (drug identification information: B004) will be 82.4%, and the risk information will be determined to be dropout risk B.

[0166] 33 is a diagram showing an example (2) of the risk of falling off in the present invention, which corresponds to the case of embodiment 3. In FIG. 33, for example, there are recipient A (recipient identification information: A001) and recipient B (recipient identification information: A002). For example, patient A is taking three types of medication as shown in (1) to (3) below. In FIG. 1, medication BA (medication identification information: B001) is prescribed by hospital CA, which is a medical institution. In FIG. 2, medication BB (medication identification information: B002) is prescribed by clinic CB, which is a medical institution. In FIG. 3, medication BC (medication identification information: B003) is prescribed by clinic CC, which is a medical institution. Also, patient B is taking two types of medication, for example, as shown in (4) and (5) below. In (4) of the same figure, medication BB (medication identification information: B002) has been prescribed by clinic CB, which is a medical institution. In (5) of the same figure, medication BD (medication identification information: B004) has been prescribed by clinic CD, which is a medical institution. It should be noted that, for the sake of convenience, the number of days for which a drug is prescribed is fixed at 14 days, and the dropout risk is judged assuming that all past prescription dates (in this case, all three prescription dates ago) are the same date. In reality, it is common for the prescription dates and number of days for which a drug is prescribed to vary at each medical institution. More specifically, in the case of FIG. 21 (1), a patient A (medication user identification information: A001) is prescribed a drug BA (medication identification information: B001) by a hospital CA, and the drug-taking period (total) is 42 days and the blank period (total) is 7 days. When this drug-taking period information and blank period information are used and applied to the compliance rate calculation rule of FIG. 21, the compliance rate becomes 85.7%, and when applied to the risk information derivation rule of FIG. 22, the risk information is determined as a dropout risk B. Similarly, in the case of FIG. 21 (2), the compliance rate for drug BB (medication identification information: B002) is 100%, and the risk information is determined as a dropout risk A. Similarly, in the case of FIG. 21 (3), the compliance rate for drug BC (medication identification information: B003) is 70.0%, and the risk information is determined as a dropout risk C. Similarly, for patient B (medicine user identification information: A002), if we consider the case of (4) in the same figure, the compliance rate for drug BB (drug identification information: B002) is 95.5%, and the risk information is determined to be dropout risk A. Similarly, if we consider the case of (5) in the same figure, the compliance rate for drug BD (drug identification information: B004) is 79.2%, and the risk information is determined to be dropout risk B. In this manner, the 'unit for determining risk information by recipient and by medication' 902 can determine risk information for each recipient and for each medication.

[0167] <Embodiment 5: Description of Configuration: Risk Information Storage Unit> The 'risk information storage unit' 1503 is configured to have a function of storing risk information determined by the above-mentioned recipient-specific drug-specific risk information determination unit in association with recipient identification information and drug identification information. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included. The risk information may be configured so that each medical institution can view it mutually if there is a consent from the patient. For example, if the compliance rate of one drug prescribed at one medical institution is low, it is expected that it may have some effect on other drugs prescribed at other medical institutions.

[0168] <Embodiment 5: Risk Assessment System: Hardware Configuration> The hardware configuration of the risk assessment system in this embodiment will be described with reference to the drawings.

[0169] Fig. 16 is a diagram showing the hardware configuration of the risk assessment system in this embodiment. As shown in this figure, the risk assessment system in this embodiment includes a "CPU (Central Processing Unit)" 1601 that performs various calculation processes, and a "main memory" 1602. It also includes a "non-volatile memory" 1603 that stores predetermined information, and a "network I / F (interface)" 1604 that transmits and receives information to and from multiple drug recipient terminals 1606 and medical staff terminals 1607. These are then connected to each other by a data communication path such as a "bus" 1605, and perform the transmission and reception of information and processing.

[0170] Here, the "main memory" reads out programs that perform various processes to be executed by the "CPU", and at the same time provides a work area that is also a work area for the programs. In addition, a plurality of addresses are assigned to each of the "main memory" and "non-volatile memory", and the programs executed by the "CPU" can exchange data with each other and perform processing by identifying and accessing the addresses. In this embodiment, the programs stored in the "main memory" are a risk information derivation rule storage program, a drug-user-specific drug-specific risk information judgment program, a risk information storage program, etc. In addition, the "main memory" and the "non-volatile memory" store drug-user identification information, drug identification information, drug-taking period information, blank period information, compliance rate calculation rules, compliance rates, risk information derivation rules, risk information, etc.

[0171] The "CPU" executes a risk information derivation rule retention program stored in the "main memory" to store risk information derivation rules in the "main memory" or "non-volatile memory." It also executes a patient-specific and drug-specific risk information determination program stored in the "main memory" to determine risk information based on patient identification information, drug identification information, medication period information, blank period information, compliance rate calculation rules, and risk information derivation rules. It also executes a risk information retention program stored in the "main memory" to store the derived risk information in the "main memory" or "non-volatile memory."

[0172] <Embodiment 5: Risk assessment system: processing flow> 17 is a diagram showing a processing flow when the risk determination system in this embodiment is used. As shown in the figure, the processing method includes a step S1701 of storing risk information derivation rules, a step S1702 of determining risk information for each drug and each user, and a step S1703 of storing risk information. These processing methods are executed by a risk determination system having a risk information derivation rule holding unit that holds risk information derivation rules, which are rules for deriving risk information representing risks arising from the medication behavior of a medication user identified by medication user identification information, based on the held compliance rate; a medication-user-specific drug-specific risk information determination unit that determines risk information for each medication user based on the medication user identification information, drug identification information, medication period information, blank period information, compliance rate calculation rules, and the risk information derivation rules; and a risk information holding unit that holds the risk information determined by the medication-user-specific drug-specific risk information determination unit in association with the medication user identification information and drug identification information.

[0173] The "risk information derivation rule storage step" S1701 is a step for storing risk information derivation rules, which are rules for deriving risk information that represents the risks that arise from the medication behavior of a medication recipient identified by medication recipient identification information, based on the stored compliance rate.

[0174] The "step for determining risk information for each drug and for each recipient" S1702 is a step for determining risk information for each drug and for each recipient based on the drug recipient identification information, drug identification information, drug-taking period information, blank period information, compliance rate calculation rules, and risk information derivation rules.

[0175] The "risk information storage step" S1703 is a step of storing the determined risk information in association with the recipient identification information and the drug identification information.

[0176] <Summary> As described above, the present invention provides a risk determination system that can determine risk information for each drug for each drug user based on drug user identification information, drug identification information, drug taking period information, blank period information, compliance rate calculation rules, and risk information derivation rules, and can retain the determined risk information in association with the drug user identification information and drug identification information.

[0177] <Embodiment 6 (corresponding mainly to claims 6, 15, and 24)> <Overview of embodiment 6> This embodiment is based on the first to fifth embodiments, and is characterized in that it includes an alert notification unit that issues an alert to alert both or either one of a recipient identified by recipient identification information and a medical professional related to the recipient, depending on the retained risk information. In order to realize this, a method executed by a CPU in a risk determination system that is a computer, and an operation program of the risk determination system that is written so as to be readable and executable by the risk determination system that is a calculator, are provided. Hereinafter, the functions, hardware configuration, and processing flow that overlap with those of the first to fifth embodiments will be omitted as appropriate.

[0178] <Functional configuration of embodiment 6> 18 is a diagram showing the functional configuration of a risk determination system in embodiment 6. In this embodiment, an alert notification unit is provided.

[0179] <Embodiment 6: Configuration of Alert Notification Unit> The "alert notification unit" 1801 is configured to have the function of issuing an alert to alert both or either one of the recipient identified by the recipient identification information and the medical professionals involved with the recipient to pay attention, depending on the retained risk information. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included. In addition, "healthcare professionals" refers to at least one or more of the following: doctors, dentists, pharmacists, public health nurses, midwives, nurses, licensed practical nurses, physical therapists, occupational therapists, orthoptists, speech-language-hearing therapists, prosthetists, radiologists, clinical x-ray technicians, clinical laboratory technicians, medical laboratory technicians, clinical engineers, dental hygienists, dental technicians, emergency medical technicians, masseurs, acupuncturists, moxibustion therapists, judo therapists, registered dietitians, nutritionists, mental health workers, social workers, care workers, certified psychologists, clinical psychologists, and medical administrators. Examples of medical professionals include doctors, dentists, and pharmacists, and the medical professional identification information for these may include, at least as a part, the medical registration number (e.g., a six-digit number) listed on the medical license, the dentist registration number (e.g., a six-digit number) listed on the dentist license, and the pharmacist registration number (e.g., a six-digit number) listed on the pharmacist license. Similarly, for other medical professionals, the medical professional identification information may include, at least as a part, the number listed on the license or qualification held.

[0180] Fig. 34 is a diagram showing an example of an alert notification in the present invention. As shown in this figure, by changing the method of alert notification depending on the level of risk information obtained, it is preferable in that it allows the recipient and medical staff to recognize the importance and urgency. In addition, it is preferable to associate in advance in the system recipient identification information that uniquely identifies the recipient and medical staff identification information that uniquely identifies the medical staff related to the recipient. Specifically, in the case of dropout risk A in FIG. 1, a part of the screen of the patient terminal 202 and / or the medical staff terminal 203 related to the patient is displayed in blue, and the patient's name, patient identification information, drug name, drug identification information, compliance rate, and risk information (dropout risk A in this case) are displayed there, and an alert is issued to encourage caution. The colors and various information displayed on the terminal screen are collectively referred to as "alert display information." In the case of dropout risk B in FIG. 1, a part of the screen of the patient terminal 202 and / or the medical staff terminal 203 related to the patient is displayed in yellow, and the patient's name, patient identification information, drug name, drug identification information, compliance rate, and risk information (dropout risk B in this case) are displayed there, and an alert is issued to encourage caution by outputting a "beep" sound from the terminal speaker once. The colors and information displayed on the device's screen are collectively referred to as "alert display information." Additionally, the sound emitted from the device's speaker is referred to as "alert sound information." In the case of dropout risk C in FIG. 3(3), a part of the screen of the drug recipient terminal 202 and / or the medical staff terminal 203 related to the drug recipient is displayed in red, and the drug recipient's name, drug recipient identification information, drug name, drug identification information, compliance rate, and risk information (dropout risk C in this case) are displayed there, and an alert is issued to call attention by outputting a "beep" sound twice in succession from the terminal's speaker. The colors and various information displayed on the terminal screen are collectively referred to as "alert display information." The sound emitted from the terminal's speaker is referred to as "alert sound information." As in this example, by changing the way in which an alert is notified depending on the level of risk information, it becomes possible to allow users and medical staff to clearly recognize the importance and urgency of the information using alert display information and alert sound information. Depending on the type of the patient terminal 202 or the medical staff terminal 203, a means for notifying by vibration such as a vibrator may be provided in advance. In such a case, in addition to the above-mentioned notification method, an alert may be notified to the patient or medical staff by the strength of the vibration or the length of the interval between vibrations. The alert notification may be configured to be sent to not only the patient and / or the medical professional associated with the patient, but also to other medical professionals, since it is assumed that the patient may receive multiple drugs prescribed by different medical institutions. In addition, an alert may be sent not only to the person taking the medicine, but also to the person's family and those caring for the person taking the medicine.

[0181] <Embodiment 6: Risk Assessment System: Hardware Configuration> The hardware configuration of the risk assessment system in this embodiment will be described with reference to the drawings.

[0182] Fig. 19 is a diagram showing the hardware configuration of the risk assessment system in this embodiment. As shown in this figure, the risk assessment system in this embodiment includes a "CPU (Central Processing Unit)" 1901 that performs various calculation processes, and a "main memory" 1902. It also includes a "non-volatile memory" 1903 that stores predetermined information, and a "network I / F (interface)" 1904 that transmits and receives information to and from a plurality of drug recipient terminals 1906 and medical staff terminals 1907. These are then interconnected by a data communication path such as a "bus" 1905, and perform the transmission and reception of information and processing.

[0183] Here, the "main memory" reads out programs that perform various processes to be executed by the "CPU", and also provides a work area that is a work area for the programs. In addition, multiple addresses are assigned to this "main memory" and "non-volatile memory", and the programs executed by the "CPU" can exchange data with each other and perform processing by identifying and accessing the addresses. In this embodiment, the programs stored in the "main memory" are, for example, an alert notification program. In addition, the "main memory" and "non-volatile memory" store, for example, patient identification information, drug identification information, risk information, alert display information, and alert sound information.

[0184] The "CPU" executes an alert notification program stored in the "main memory" and, depending on the retained risk information, issues an alert to alert the drug recipient identified by the drug recipient identification information and / or medical professionals involved with the drug recipient to pay attention.

[0185] <Embodiment 6: Risk assessment system: processing flow> 20 is a diagram showing a process flow when the risk determination system in this embodiment is used. As shown in the diagram, the process method includes an alert notification step S2001. These processing methods are executed by a risk assessment system having an alert notification unit that issues an alert to alert both or either one of the drug recipient identified by the drug recipient identification information and medical professionals involved with the drug recipient to pay attention, depending on the retained risk information.

[0186] The "alert notification step" S2001 is a step in which an alert is issued to alert the drug recipient identified by the drug recipient identification information and / or the medical professionals involved with the drug recipient, depending on the retained risk information.

[0187] <Summary> As described above, the present invention provides a risk assessment system that is capable of issuing an alert to encourage caution to a drug recipient identified by drug recipient identification information and / or medical professionals involved with the drug recipient, depending on the retained risk information.

[0188] <Embodiment 7 (corresponding mainly to claims 7, 16, and 25)> <Overview of embodiment 7> Based on the first to sixth embodiments, the present embodiment is characterized in that it includes a medication instruction advice information storage unit that stores advice information on medication instruction for a drug prescribed to a user in association with the user identification information, a medication instruction advice information update unit that can update the advice information on medication instruction stored in the medication instruction advice information storage unit according to the risk information stored in the risk information storage unit, and a medication instruction advice information output unit that outputs the advice information on medication instruction updated in the medication instruction advice information update unit to both or either of the user identified by the user identification information and the medical worker related to the user. In order to realize this, a method executed by a CPU in a risk determination system that is a computer, and an operation program of the risk determination system that is written so as to be readable and executable by the risk determination system that is a calculator are provided. Hereinafter, the functions, hardware configurations, and processing flows that overlap with those of the first to sixth embodiments will be omitted as appropriate.

[0189] <Functional configuration of embodiment 7> 21 is a diagram showing the functional configuration of the risk assessment system in embodiment 7. In this embodiment, the risk assessment system includes a medication instruction advice information storage unit, a medication instruction advice information update unit, and a medication instruction advice information output unit.

[0190] <Embodiment 7 Configuration: Medication Instruction Advice Information Storage Unit> The 'medication instruction advice information storage unit' 2101 is configured to have a function of storing advice information regarding medication instruction for the medicine prescribed to a medication recipient in association with medication recipient identification information. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0191] <Embodiment 7 Configuration: Medication Instruction Advice Information Update Unit> The 'medication instruction advice information update unit' 2102 is configured to have a function of enabling the advice information regarding medication instruction stored in the medication instruction advice information storage unit described above to be updated in accordance with the stored risk information. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included.

[0192] Fig. 35 is a diagram showing an example of medication instruction advice information in the present invention. As shown in this diagram, by appropriately changing the content of the medication instruction advice depending on the level of the obtained risk information, it is preferable in that it allows the user and medical staff to recognize the importance and urgency of the medication instruction advice. For example, in the case of dropout risk A in Figure (1), the medication instruction advice information includes the name of the patient, the patient identification information, the drug name, and the drug identification information, and the medication instruction advice is updated to the specific content, "You are taking the medication in compliance with the drug usage and dosage. This is great. Let's keep it up like this! If any problems arise, please consult a doctor or pharmacist." Also, in the case of dropout risk B in Figure (2), the medication instruction advice information includes the name of the patient, the patient identification information, the drug name, and the drug identification information, and the medication instruction advice is updated to the specific content, "You are not taking the medication in compliance with the drug usage and dosage. Your medication compliance rate is getting worse. Improvement is needed! If you have any problems, please consult a doctor or pharmacist." In addition, in the case of dropout risk C in the same figure (3), the name of the patient, patient identification information, drug name, and drug identification information are included as part of the medication instruction advice information, and the medication instruction advice is updated to be more specific, such as, "The patient is not taking the medication in accordance with the drug usage and dosage instructions. The drug compliance rate has deteriorated significantly! Immediate improvement is essential! Please consult a doctor or pharmacist as soon as possible to identify the cause and take measures."

[0193] In addition to the above, artificial intelligence may be used to learn various types of health and medical information that have been accumulated in advance in a "health and medical information sharing system" or the like, and then risk information may be input to enable the selection of appropriate medication instruction advice information.

[0194] Here, "health and medical information" refers to an individual's electronic medical record information, various test information (which may include health checkups, medical examinations, etc.), prescription information, medication history information, medication status information, vital signs information (e.g., including at least, but not limited to, body temperature, blood pressure, pulse, heart rate, height, weight, blood glucose level, body fat percentage, arterial blood oxygen saturation, electroencephalogram, electrocardiogram, number of steps, respiratory rate, heart sounds, urine measurement information (e.g., urinary sugar, urinary protein, urinary occult blood, urobilinogen, pH, bilirubin, ketone bodies, nitrites, etc.), sleep time, etc.), information from medical questionnaires, data from health promotion apps, conversation data from interactive health promotion SNS, etc.

[0195] In addition, the "electronic medical record information" may include, for example, basic information about the patient (e.g., patient ID, name, date of birth, contact information, emergency contact information, family history, height and weight, allergy information, smoking and drinking status, medical history, etc.), information about the examination (e.g., the patient's main complaint (subjective symptoms and complaints about physical condition, etc.), various test results, medication information, diagnosis, treatment plan, doctor's examination record, doctor's instructions, etc.), information about nursing and progress (e.g., vital signs information (e.g., body temperature, blood pressure, pulse, heart rate, height, weight, blood glucose level, body fat percentage, arterial blood oxygen saturation, brain wave, electrocardiogram, number of steps, respiratory rate, heart sound, urine measurement information (e.g., urinary sugar, urinary protein, urinary occult blood, uro It may also include, but is not limited to, bilinogen, pH, bilirubin, ketone bodies, nitrites, etc.), sleep time, etc.), observation results, records of urine and stool, records of food content and intake, records of nursing care, etc.), information regarding tests (e.g., test instructions, test results, images (partially) obtained from imaging tests, reports on those images, etc.), information regarding treatment or surgery (e.g., instructions for treatment or surgery, progress and results of treatment or surgery, method and diagnosis if a pathological diagnosis was performed, etc.), information regarding medication (e.g., medication instructions, date and time of medication and medication, results of medication, etc.), and follow-up information after treatment or surgery.

[0196] In addition, "prescription information" may include, for example, the insurer number, name, date of birth, sex, name of the medical institution, contact information, name of the prescribing doctor, name of the medication, form of the medication (tablet, capsule, liquid, powder, granule, etc.), amount of medication (amount to take per dose), number of times to take per day, timing of taking, information about changing to generic drugs, number of times of divided dispensing, etc. In addition, "medicinal history information" may include, for example, the patient's name, date of birth, sex, insured person's card number, address, emergency contact information, name of the prescribed medical institution and name of the insured physician, prescription date, prescription contents, dispensing date, key points of inquiries regarding the prescription contents, the patient's constitution, allergy history, side effect history, key points of inquiries from the patient or their family, medication status, confirmation of remaining medication status, changes in physical condition while taking the medication, concomitant medications, medical history information including complications, whether the patient has visited another department, whether or not there are symptoms that are suspected to be side effects, food and drink intake (drug interactions), the patient's wishes regarding the use of generic drugs, the status of information provided in the notebook, key points of medication instructions, name of the insured pharmacist who provided instructions, and medication status information.

[0197] In addition, "medication status information" may include, for example, information regarding the remaining amount of prescribed medication (including, for example, the amount of medication remaining if the patient accidentally forgets to take the medication or if the patient intentionally does not take the medication), timing information regarding visits to the hospital / clinic (for example, the period from the scheduled end date of the prescription (scheduled end date of medication) to the actual visit to the hospital / clinic (including, for example, a visit to the hospital / clinic earlier than scheduled or later than scheduled)), and patient complaints about medication (including subjective symptoms and complaints about physical condition, such as developing hives after taking a certain medication continuously, or feeling dizzy after taking a certain medication because it was too effective). For example, in the case where a drug A is prescribed at a medical institution A and a drug B is prescribed at a medical institution B, if there is a case where the compliance rate for drug B is significantly lower than that for drug A, it is estimated that the patient may have a problem with taking the drug. Based on such an estimation, the system may be configured to provide appropriate medication instruction advice information as needed.

[0198] <Embodiment 7 Configuration: Medication Instruction Advice Information Output Unit> The "medication instruction advice information output unit" 2103 is configured to have the function of outputting advice information regarding medication instructions updated by the above-mentioned medication instruction advice information update unit to both or either the medication user identified by the medication user identification information and the medical professional related to the medication user. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included. In addition, "healthcare professionals" refers to at least one or more of the following: doctors, dentists, pharmacists, public health nurses, midwives, nurses, licensed practical nurses, physical therapists, occupational therapists, orthoptists, speech-language-hearing therapists, prosthetists, radiologists, clinical x-ray technicians, clinical laboratory technicians, medical laboratory technicians, clinical engineers, dental hygienists, dental technicians, emergency medical technicians, masseurs, acupuncturists, moxibustion therapists, judo therapists, registered dietitians, nutritionists, mental health workers, social workers, care workers, certified psychologists, clinical psychologists, and medical administrators. Examples of medical professionals include doctors, dentists, and pharmacists, and the medical professional identification information for these may include, at least as a part, the medical registration number (e.g., a six-digit number) listed on the medical license, the dentist registration number (e.g., a six-digit number) listed on the dentist license, and the pharmacist registration number (e.g., a six-digit number) listed on the pharmacist license. Similarly, for other medical professionals, the medical professional identification information may include, at least as a part, the number listed on the license or qualification held.

[0199] FIG. 35 is a diagram showing an example of medication instruction advice information in the present invention. As shown in this figure, it is preferable that the medication instruction advice can be appropriately changed according to the level of the obtained risk information, thereby making the recipient and medical staff aware of the importance and urgency of the medication instruction advice. In addition, it is preferable that the recipient identification information that uniquely identifies the recipient and the medical staff identification information that uniquely identifies the medical staff related to the recipient are associated in advance in the system. In this way, it becomes possible to output medication instruction advice information to both the recipient and the medical staff related to the recipient, or to either one of them. For example, in the case of dropout risk A in FIG. 1, the medication instruction advice information includes the name of the recipient, the recipient identification information, the drug name, and the drug identification information, and the medication instruction advice is updated to the specific content, "You are taking the medicine in compliance with the drug dosage and administration instructions. This is excellent. Let's keep it up like this! If any problems occur, please consult a doctor or pharmacist." The medication instruction advice information is output to both or either of the recipient terminal 202 and the medical staff terminal 203. In addition, in the case of dropout risk B in FIG. 2, the medication instruction advice information includes the name of the recipient, the recipient identification information, the drug name, and the drug identification information, and the medication instruction advice is updated to the specific content, "You are not taking the medicine in compliance with the drug dosage and administration instructions. Your compliance rate with the drug is getting worse. Improvement is required! If you have any problems, please consult a doctor or pharmacist." The medication instruction advice information is output to both or either of the recipient terminal 202 and the medical staff terminal 203. In addition, in the case of dropout risk C in the same figure (3), the medication instruction advice information includes the name of the medication recipient, medication recipient identification information, medication name, and medication identification information, and the medication instruction advice is updated to the specific content, "The medication is not being taken in accordance with the dosage and administration instructions. The medication compliance rate has deteriorated significantly! Prompt improvement is essential! Please consult a doctor or pharmacist as soon as possible to identify the cause and take measures!", and the medication instruction advice information is output to both or either one of the medication recipient terminal 202 and the medical staff terminal 203. As in this example, by specifically updating and outputting the content of the medication instruction advice information depending on the level of risk information, it becomes possible for patients and medical professionals to clearly understand the importance and urgency of the content of the medication instruction advice. The system may be configured so that medication advice information can be output not only to the person taking the medicine, but also to the person's family and those caring for the person taking the medicine.

[0200] <Embodiment 7: Risk Assessment System: Hardware Configuration> The hardware configuration of the risk assessment system in this embodiment will be described with reference to the drawings.

[0201] Fig. 22 is a diagram showing the hardware configuration of the risk assessment system in this embodiment. As shown in this figure, the risk assessment system in this embodiment includes a "CPU (Central Processing Unit)" 2201 that performs various calculation processes, and a "main memory" 2202. It also includes a "non-volatile memory" 2203 that stores predetermined information, and a "network I / F (interface)" 2204 that transmits and receives information to and from a plurality of drug recipient terminals 2206 and medical worker terminals 2207. These are then interconnected by a data communication path such as a "bus" 2205, and perform the transmission and reception of information and processing.

[0202] Here, the "main memory" reads out programs that perform various processes to be executed by the "CPU", and at the same time provides a work area that is also a work area for the programs. In addition, multiple addresses are assigned to this "main memory" and "non-volatile memory", and the programs executed by the "CPU" can exchange data with each other and perform processing by identifying and accessing the addresses. In this embodiment, the programs stored in the "main memory" are a medication instruction advice information holding program, a medication instruction advice information updating program, a medication instruction advice information output program, etc. In addition, the "main memory" and "non-volatile memory" store medication user identification information, drug identification information, risk information, medication instruction advice information, etc.

[0203] The "CPU" executes a medication instruction advice holding program stored in the "main memory" to store medication instruction advice information in the "main memory" and / or the "non-volatile memory." It also executes a medication instruction advice information update program stored in the "main memory" to update the medication instruction advice information in accordance with risk information. It also executes a medication instruction advice information output program stored in the "main memory" to output the updated medication instruction advice information to both or either one of the recipient identified by the recipient identification information and the medical professional associated with the recipient.

[0204] <Embodiment 7: Risk assessment system: processing flow> 23 is a diagram showing a process flow when the risk determination system in this embodiment is used. As shown in the figure, the process method includes a medication instruction advice information storage step S2301, a medication instruction advice information update step S2302, and a medication instruction advice information output step S2303. These processing methods are executed by a risk assessment system having a medication instruction advice information holding unit that holds advice information regarding medication instructions for medication prescribed to a medication recipient in association with medication recipient identification information, a medication instruction advice information updating unit that can update the advice information regarding medication instructions held in the medication instruction advice information holding unit according to the held risk information, and a medication instruction advice information output unit that outputs the advice information regarding medication instructions updated by the medication instruction advice information updating unit to both or either of the medication recipient identified by the medication recipient identification information and the medical professional associated with the medication recipient.

[0205] The "medication instruction advice information storage step" S2301 is a step of storing advice information regarding medication instruction for the medicine prescribed to the medicine recipient in association with the medicine recipient identification information.

[0206] The "medication instruction advice information update step" S2302 is a step of updating advice information regarding medication instruction stored in the medication instruction advice information storage step in accordance with the stored risk information.

[0207] The "medication instruction advice information output step" S2303 is a step in which advice information regarding medication instructions updated in the medication instruction advice information update step is output to both or either the medication user identified by the medication user identification information and the medical professional related to the medication user.

[0208] <Summary> As described above, the present invention provides a risk assessment system that can update retained advice information regarding medication instructions in accordance with retained risk information, and output the updated advice information regarding medication instructions to both the user and / or medical professionals involved with the user.

[0209] <Embodiment 8 (corresponding mainly to claims 8, 17, and 26)> <Overview of embodiment 8> This embodiment is based on the first to seventh embodiments, and is characterized by including a risk information output unit capable of outputting the retained risk information to the outside based on the consent of the recipient identified by the recipient identification information. In order to realize this, a method executed by a CPU in a risk determination system, which is a computer, and an operating program for the risk determination system, which is written so as to be readable and executable by the risk determination system, which is a calculator, are provided. Hereinafter, the functions, hardware configuration, and process flow that overlap with those of the first to seventh embodiments will be omitted as appropriate.

[0210] <Functional configuration of embodiment 8> 24 is a diagram showing the functional configuration of a risk determination system in embodiment 8. In this embodiment, a risk information output unit is provided.

[0211] <Embodiment 8: Description of Configuration: Risk Information Output Unit> The 'risk information output section' 2401 is configured to have a function capable of outputting the retained risk information to the outside, based on the consent of the recipient identified by the recipient identification information. In addition, it is preferable that the "medication recipient identification information" includes at least one of the following information: My Number information, the symbol and number on a social insurance or national health insurance certificate, and a nursing care insurance number. In addition, the "drug identification information" preferably includes one or more of the following: drug price standard listed drug code (Ministry of Health, Labor and Welfare code: 12 alphanumeric characters), individual drug code (YJ code: 12 alphanumeric characters), JAN code (standard type) (JAN code: 13 digit number), etc. In addition to these, there are many types of codes given to drugs for different purposes, and these may also be included. Also, for example, it is preferable to provide a "consent information receiving means" in the risk information output unit 2401 so that the system can receive consent information indicating that the user consents to the risk information for the drug he or she is taking being output to the outside. On the other hand, a "consent information output means" may be provided in the user terminal 202 so that the user can select a drug and output the consent information indicating that the user consents to the risk information for the drug he or she is taking being output to the outside, or the user can output the consent information for the drug all at once.

[0212] <Embodiment 8: Risk Assessment System: Hardware Configuration> The hardware configuration of the risk assessment system in this embodiment will be described with reference to the drawings.

[0213] Fig. 25 is a diagram showing the hardware configuration of the risk assessment system in this embodiment. As shown in this figure, the risk assessment system in this embodiment includes a "CPU (Central Processing Unit)" 2501 that performs various calculation processes, and a "main memory" 2502. It also includes a "non-volatile memory" 2503 that stores predetermined information, and a "network I / F (interface)" 2504 that transmits and receives information to and from a plurality of drug recipient terminals 2506 and medical worker terminals 2507. These are connected to each other by a data communication path such as a "bus" 2505, and perform the transmission and reception of information and processing.

[0214] Here, the "main memory" reads out programs that perform various processes to be executed by the "CPU", and also provides a work area that is a working area for the programs. In addition, multiple addresses are assigned to this "main memory" and "non-volatile memory", and the programs executed by the "CPU" can exchange data with each other and perform processing by identifying and accessing those addresses. In this embodiment, the program stored in the "main memory" is a risk information output program, etc. In addition, the "main memory" and "non-volatile memory" store patient identification information, drug identification information, risk information, consent information, etc.

[0215] The "CPU" executes a risk information output program stored in the "main memory" and outputs the retained risk information to the outside based on the consent of the recipient identified by the recipient identification information.

[0216] <Embodiment 8: Risk assessment system: processing flow> 26 is a diagram showing a process flow when the risk determination system in this embodiment is used. As shown in the diagram, this is a processing method including a risk information output step S2601. These processing methods are executed by a risk assessment system having a risk information output unit that can output the retained risk information to the outside based on the consent of the drug recipient identified by the drug recipient identification information.

[0217] The "risk information output step" S2601 is a step of outputting the retained risk information to the outside based on the consent of the recipient identified by the recipient identification information.

[0218] <Summary> As described above, the present invention can provide a risk assessment system that can output retained risk information to the outside based on the consent of a drug recipient identified by drug recipient identification information. [Explanation of symbols]

[0219] Risk assessment system: 201, 300 Drug user terminal: 202 Medical staff terminal: 203 Network: 204 Drug user identification information storage unit: 301 Drug identification information storage unit: 302 Drug delivery history information storage unit: 303 Previous prescription date information acquisition section: 304 Previous prescription date information acquisition section: 305 Medication period information acquisition unit: 306 Medication period information storage unit: 307 Blank period information acquisition part: 308 Blank period information holding section: 309 Compliance rate calculation rule storage unit: 310 Compliance rate calculation department: 311 Compliance rate retention section: 312

Claims

1. A patient identification information storage unit that stores patient identification information, which is information for uniquely identifying a patient who takes a drug indicated in the information related to the provision of medicines; A drug identification information storage unit that stores drug identification information, which is information for uniquely identifying a drug indicated in information related to the provision of medicines; A drug delivery history information storage unit that stores history information on information related to delivery of drugs, including drug identification information, for a drug recipient identified by the drug recipient identification information stored in the drug recipient identification information storage unit; a previous prescription date information acquisition unit that acquires previous prescription date information associated with the drug identification information of the dispensed drug, the previous prescription date information indicating the prescription date of the drug identified by the previous drug identification information of the drug recipient identified by the drug recipient identification information; a current prescription date information acquisition unit that acquires current prescription date information associated with the drug identification information of the dispensed drug, the current prescription date information indicating the prescription date of the drug identified by the current drug identification information of the drug recipient identified by the drug recipient identification information; a medication period information acquisition unit that acquires medication period information from the pharmaceutical payment history information in association with medication identification information that identifies the medication to be provided, the medication period information being information representing a period from a previous prescription date to a current prescription date during which the medication that should be taken is theoretically present; a medication period information storage unit that stores the medication period information acquired by the medication period information acquisition unit in association with drug identification information; a blank period information acquisition unit that acquires blank period information from the pharmaceutical delivery history information in association with pharmaceutical identification information that identifies the pharmaceutical to be delivered, the blank period information being information representing a period from a previous prescription date to a current prescription date during which no pharmaceutical to be taken is theoretically available; a blank period information storage unit that stores the blank period information acquired by the blank period information acquisition unit in association with the medicine identification information; a compliance rate calculation rule storage unit that stores, in association with drug identification information, compliance rate calculation rules for calculating a compliance rate indicating that a drug user is taking a target drug in compliance with dosage and administration based on drug-taking period information and blank period information; a compliance rate calculation unit that calculates a compliance rate for each drug for each drug recipient based on the drug recipient identification information, the drug identification information, the drug taking period information, the blank period information, and a compliance rate calculation rule; a compliance rate storage unit that stores the compliance rate calculated by the compliance rate calculation unit in association with medicine identification information; A risk assessment system comprising:

2. a statistical processing unit that performs statistical processing on the compliance rate stored in the compliance rate storage unit for each piece of medicine identification information; a statistical processing result storage unit that stores a statistical processing result in the statistical processing unit; a statistical processing result output unit that outputs the statistical processing result stored in the statistical processing result storage unit; The risk assessment system according to claim 1, further comprising:

3. A patient identification information storage unit that stores patient identification information, which is information for uniquely identifying a patient who takes a drug indicated in the information related to the provision of medicines; A drug identification information storage unit that stores drug identification information, which is information for uniquely identifying a drug indicated in information related to the provision of medicines; A drug delivery history information storage unit that stores history information on information related to delivery of drugs, including drug identification information, for a drug recipient identified by the drug recipient identification information stored in the drug recipient identification information storage unit; a current prescription date information acquisition unit that acquires current prescription date information associated with the drug identification information of the dispensed drug, the current prescription date information indicating the prescription date of the drug identified by the current drug identification information of the drug recipient identified by the drug recipient identification information; a past prescription date information acquisition unit that acquires past prescription date information associated with the drug identification information of a dispensed drug, the past prescription date information indicating a prescription date of a drug identified by past drug identification information of a drug recipient identified by the drug recipient identification information; a medication period information acquisition unit that acquires medication period information, which is information representing a period from a previous prescription date to a current prescription date, during which a drug that should theoretically be taken exists, from the pharmaceutical payment history information; a medication period information storage unit that stores the medication period information acquired by the medication period information acquisition unit in association with drug identification information; a blank period information acquisition unit that acquires blank period information, which is information representing a period from a past prescription date to a current prescription date during which no medication that should be taken is theoretically available, from pharmaceutical delivery history information; a blank period information storage unit that stores the blank period information acquired by the blank period information acquisition unit in association with the medicine identification information; a compliance rate calculation rule storage unit that stores, in association with drug identification information, compliance rate calculation rules for calculating a compliance rate indicating that a drug user is taking a target drug in compliance with dosage and administration based on drug-taking period information and blank period information; a compliance rate calculation unit that calculates a compliance rate for each drug for each drug recipient based on the drug recipient identification information, the drug identification information, the drug taking period information, the blank period information, and a compliance rate calculation rule; a compliance rate storage unit that stores the compliance rate calculated by the compliance rate calculation unit in association with medicine identification information; A risk assessment system comprising:

4. a statistical processing unit that performs statistical processing on the compliance rate stored in the compliance rate storage unit for each piece of medicine identification information; a statistical processing result storage unit that stores a statistical processing result in the statistical processing unit; a statistical processing result output unit that outputs the statistical processing result stored in the statistical processing result storage unit; 4. The risk assessment system according to claim 3, further comprising:

5. a risk information derivation rule storage unit for storing risk information derivation rules, which are rules for deriving risk information representing risks that arise due to the medication behavior of a medication recipient identified by the medication recipient identification information, based on the compliance rate stored in the compliance rate storage unit; a patient-specific drug-specific risk information determination unit that determines risk information for each drug for each patient based on patient identification information, drug identification information, drug-taking period information, blank period information, compliance rate calculation rules, and risk information derivation rules; a risk information storage unit that stores the risk information determined by the patient-specific drug-specific risk information determination unit in association with patient identification information and drug identification information; The risk assessment system according to claim 1 or 3, further comprising:

6. The risk assessment system described in claim 5, further characterized in that it further has an alert notification unit that issues an alert to both or either one of the drug recipient identified by the drug recipient identification information and medical professionals related to the drug recipient to alert them to the risk information stored in the risk information storage unit.

7. a medication instruction advice information storage unit that stores advice information regarding medication instruction for a drug prescribed to a medication recipient in association with medication recipient identification information; a medication instruction advice information update unit capable of updating advice information regarding medication instruction stored in the medication instruction advice information storage unit in accordance with the risk information stored in the risk information storage unit; a medication instruction advice information output unit that outputs the medication instruction advice information updated by the medication instruction advice information update unit to both or either one of a recipient identified by the recipient identification information and a medical professional related to the recipient; 6. The risk assessment system according to claim 5, further comprising:

8. The risk assessment system described in claim 5, further characterized by having a risk information output unit capable of outputting the risk information stored in the risk information storage unit to the outside based on the consent of the drug recipient identified by the drug recipient identification information.

9. The risk assessment system described in claim 1 or claim 3, characterized in that the medication user identification information includes at least one of the following information: My Number information, the symbol / number of a social insurance or national health insurance certificate, and a nursing care insurance certificate number.

10. A method executed by a CPU in a risk determination system that is a computer, comprising: A patient identification information storage step for storing patient identification information which is information for uniquely identifying a patient who takes a drug indicated in the information related to the provision of medicine; A drug identification information storage step for storing drug identification information which is information for uniquely identifying a drug indicated in information related to the provision of medicine; A drug delivery history information storage step for storing history information of information related to delivery of a drug, including drug identification information, to a drug recipient identified by the drug recipient identification information stored in the drug recipient identification information storage step; A previous prescription date information acquisition step of acquiring previous prescription date information associated with the drug identification information of the dispensed drug, the previous prescription date information indicating the prescription date of the drug identified by the previous drug identification information of the drug recipient identified by the drug recipient identification information; A current prescription date information acquisition step of acquiring current prescription date information associated with the drug identification information of the dispensed drug, the current prescription date information indicating the prescription date of the drug identified by the current drug identification information of the drug recipient identified by the drug recipient identification information; a medication period information acquisition step of acquiring, from the pharmaceutical delivery history information, medication period information, which is information representing a period from a previous prescription date to a current prescription date, in association with medication identification information that identifies the medication to be delivered, and which indicates a period during which the medication that should be taken is theoretically present; a medication period information storage step of storing the medication period information acquired in the medication period information acquisition step in association with the drug identification information; a blank period information acquisition step of acquiring blank period information from the pharmaceutical delivery history information in association with pharmaceutical identification information that identifies the pharmaceutical to be delivered, the blank period information being information representing a period from a previous prescription date to a current prescription date during which no pharmaceutical to be taken is theoretically available; A blank period information storage step of storing the blank period information acquired in the blank period information acquisition step in association with the medicine identification information; a compliance calculation rule storage step of storing, in association with the drug identification information, a compliance calculation rule for calculating a compliance rate indicating that the drug user is taking the target drug in compliance with the dosage and administration based on the drug-taking period information and the blank period information; a compliance rate calculation step of calculating a compliance rate for each drug for each drug recipient based on the drug recipient identification information, the drug identification information, the drug taking period information, the blank period information, and a compliance rate calculation rule; a compliance rate storage step of storing the compliance rate calculated in the compliance rate calculation step in association with the medicine identification information; The method according to claim 1, further comprising:

11. A method executed by a CPU in a risk determination system that is a computer, comprising: a statistical processing step of statistically processing the compliance rate stored in the compliance rate storage step for each piece of medicine identifying information; a statistical processing result storage step for storing a statistical processing result in the statistical processing step; a statistical processing result output step for outputting the statistical processing result held in the statistical processing result holding step; 11. The method of claim 10, comprising:

12. A method executed by a CPU in a risk determination system that is a computer, comprising: A patient identification information storage step for storing patient identification information which is information for uniquely identifying a patient who takes a drug indicated in the information related to the provision of medicine; A drug identification information storage step for storing drug identification information which is information for uniquely identifying a drug indicated in information related to the provision of medicine; A drug delivery history information storage step for storing history information of information related to delivery of a drug, including drug identification information, to a drug recipient identified by the drug recipient identification information stored in the drug recipient identification information storage step; A current prescription date information acquisition step of acquiring current prescription date information associated with the drug identification information of the dispensed drug, the current prescription date information indicating the prescription date of the drug identified by the current drug identification information of the drug recipient identified by the drug recipient identification information; A past prescription date information acquisition step of acquiring past prescription date information associated with the drug identification information of the dispensed drug, the past prescription date information indicating the prescription date of the drug identified by the past drug identification information of the drug recipient identified by the drug recipient identification information; A medication period information acquisition step of acquiring medication period information, which is information representing a period from a past prescription date to a current prescription date, during which a drug that should be taken is theoretically present, from the pharmaceutical benefit history information; a medication period information storage step of storing the medication period information acquired in the medication period information acquisition step in association with the drug identification information; A blank period information acquisition step of acquiring blank period information, which is information representing a period from a past prescription date to a current prescription date during which no medication that should be taken is theoretically present, from the pharmaceutical delivery history information; A blank period information storage step of storing the blank period information acquired in the blank period information acquisition step in association with the medicine identification information; a compliance calculation rule storage step of storing, in association with the drug identification information, a compliance calculation rule for calculating a compliance rate indicating that the drug user is taking the target drug in compliance with the dosage and administration based on the drug-taking period information and the blank period information; a compliance rate calculation step of calculating a compliance rate for each drug for each drug recipient based on the drug recipient identification information, the drug identification information, the drug taking period information, the blank period information, and a compliance rate calculation rule; a compliance rate storage step of storing the compliance rate calculated in the compliance rate calculation step in association with the medicine identification information; The method according to claim 1, further comprising:

13. A method executed by a CPU in a risk determination system that is a computer, comprising: a statistical processing step of statistically processing the compliance rate stored in the compliance rate storage step for each piece of medicine identifying information; a statistical processing result storage step for storing a statistical processing result in the statistical processing step; a statistical processing result output step for outputting the statistical processing result held in the statistical processing result holding step; 13. The method of claim 12, comprising:

14. A method executed by a CPU in a risk determination system that is a computer, comprising: a risk information derivation rule storage step for storing risk information derivation rules, which are rules for deriving risk information representing risks that arise due to the medication behavior of a medication recipient identified by the medication recipient identification information, based on the compliance rate stored in the compliance rate storage step; a patient-specific drug-specific risk information determination step for determining risk information for each patient based on patient identification information, drug identification information, drug-taking period information, blank period information, compliance rate calculation rules, and risk information derivation rules; a risk information storage step of storing the risk information determined in the risk information determination step for determining risk information for each patient and each drug in association with the patient identification information and the drug identification information; 13. The method of claim 10 or claim 12, further comprising:

15. A method executed by a CPU in a risk determination system that is a computer, comprising: The method according to claim 14, further comprising an alert notification step of issuing an alert to alert both or either one of a recipient identified by the recipient identification information and a medical professional associated with the recipient to pay attention to the risk information retained in the risk information retention step.

16. A method executed by a CPU in a risk determination system that is a computer, comprising: a medication instruction advice information storage step of storing advice information regarding medication instruction for a drug prescribed to a medication recipient in association with medication recipient identification information; a medication instruction advice information updating step capable of updating advice information regarding medication instruction held in the medication instruction advice information holding step according to the risk information held in the risk information holding step; a medication instruction advice information output step of outputting the advice information regarding medication instruction updated in the medication instruction advice information update step to both or either one of a user identified by the user identification information and a medical professional related to the user; 15. The method of claim 14 further comprising:

17. A method executed by a CPU in a risk determination system that is a computer, comprising: The method according to claim 14, further comprising a risk information output step capable of outputting the risk information retained in the risk information retaining step to an external source based on the consent of the recipient identified by the recipient identification information.

18. A method executed by a CPU in a risk determination system that is a computer, comprising: The method according to claim 10 or 12, characterized in that the medication recipient identification information includes at least one or more of the following information: My Number information, the symbol / number of a social insurance or national health insurance certificate, and a nursing care insurance certificate number.

19. A patient identification information storage step for storing patient identification information which is information for uniquely identifying a patient who takes a drug indicated in the information related to the provision of medicine; A drug identification information storage step for storing drug identification information which is information for uniquely identifying a drug indicated in information related to the provision of medicine; A drug delivery history information storage step for storing history information of information related to delivery of a drug, including drug identification information, to a drug recipient identified by the drug recipient identification information stored in the drug recipient identification information storage step; A previous prescription date information acquisition step of acquiring previous prescription date information associated with the drug identification information of the dispensed drug, the previous prescription date information indicating the prescription date of the drug identified by the previous drug identification information of the drug recipient identified by the drug recipient identification information; A current prescription date information acquisition step of acquiring current prescription date information associated with the drug identification information of the dispensed drug, the current prescription date information indicating the prescription date of the drug identified by the current drug identification information of the drug recipient identified by the drug recipient identification information; a medication period information acquisition step of acquiring, from the pharmaceutical delivery history information, medication period information, which is information representing a period from a previous prescription date to a current prescription date, in association with medication identification information that identifies the medication to be delivered, and which indicates a period during which the medication that should be taken is theoretically present; a medication period information storage step of storing the medication period information acquired in the medication period information acquisition step in association with the drug identification information; a blank period information acquisition step of acquiring blank period information from the pharmaceutical delivery history information in association with pharmaceutical identification information that identifies the pharmaceutical to be delivered, the blank period information being information representing a period from a previous prescription date to a current prescription date during which no pharmaceutical to be taken is theoretically available; A blank period information storage step of storing the blank period information acquired in the blank period information acquisition step in association with the medicine identification information; a compliance calculation rule storage step of storing, in association with the drug identification information, a compliance calculation rule for calculating a compliance rate indicating that the drug user is taking the target drug in compliance with the dosage and administration based on the drug-taking period information and the blank period information; a compliance rate calculation step of calculating a compliance rate for each drug for each drug recipient based on the drug recipient identification information, the drug identification information, the drug taking period information, the blank period information, and a compliance rate calculation rule; a compliance rate storage step of storing the compliance rate calculated in the compliance rate calculation step in association with the medicine identification information; 2. A risk assessment system comprising: a computer program for executing a risk assessment system, the computer program being capable of reading and executing a risk assessment system;

20. a statistical processing step of statistically processing the compliance rate stored in the compliance rate storage step for each piece of medicine identifying information; a statistical processing result storage step for storing a statistical processing result in the statistical processing step; a statistical processing result output step for outputting the statistical processing result held in the statistical processing result holding step; A method for an operating program of a risk assessment system, which is written in a readable and executable manner in a risk assessment system which is a computer as described in claim 19.

21. A patient identification information storage step for storing patient identification information which is information for uniquely identifying a patient who takes a drug indicated in the information related to the provision of medicine; A drug identification information storage step for storing drug identification information which is information for uniquely identifying a drug indicated in information related to the provision of medicine; A drug delivery history information storage step for storing history information of information related to delivery of a drug, including drug identification information, to a drug recipient identified by the drug recipient identification information stored in the drug recipient identification information storage step; A current prescription date information acquisition step of acquiring current prescription date information associated with the drug identification information of the dispensed drug, the current prescription date information indicating the prescription date of the drug identified by the current drug identification information of the drug recipient identified by the drug recipient identification information; A past prescription date information acquisition step of acquiring past prescription date information associated with the drug identification information of the dispensed drug, the past prescription date information indicating the prescription date of the drug identified by the past drug identification information of the drug recipient identified by the drug recipient identification information; A medication period information acquisition step of acquiring medication period information, which is information representing a period from a past prescription date to a current prescription date, during which a drug that should be taken is theoretically present, from the pharmaceutical benefit history information; a medication period information storage step of storing the medication period information acquired in the medication period information acquisition step in association with the drug identification information; A blank period information acquisition step of acquiring blank period information, which is information representing a period from a past prescription date to a current prescription date during which no medication that should be taken is theoretically present, from the pharmaceutical delivery history information; A blank period information storage step of storing the blank period information acquired in the blank period information acquisition step in association with the medicine identification information; a compliance calculation rule storage step of storing, in association with the drug identification information, a compliance calculation rule for calculating a compliance rate indicating that the drug user is taking the target drug in compliance with the dosage and administration based on the drug-taking period information and the blank period information; a compliance rate calculation step of calculating a compliance rate for each drug for each drug recipient based on the drug recipient identification information, the drug identification information, the drug taking period information, the blank period information, and a compliance rate calculation rule; a compliance rate storage step of storing the compliance rate calculated in the compliance rate calculation step in association with the medicine identification information; 2. A risk assessment system comprising: a computer program for executing a risk assessment system, the computer program being capable of reading and executing a risk assessment system;

22. a statistical processing step of statistically processing the compliance rate stored in the compliance rate storage step for each piece of medicine identifying information; a statistical processing result storage step for storing a statistical processing result in the statistical processing step; a statistical processing result output step for outputting the statistical processing result held in the statistical processing result holding step; A method for an operating program of a risk assessment system, which is written in a readable and executable manner in a risk assessment system which is a computer as described in claim 21.

23. a risk information derivation rule storage step for storing risk information derivation rules, which are rules for deriving risk information representing risks that arise due to the medication behavior of a medication recipient identified by the medication recipient identification information, based on the compliance rate stored in the compliance rate storage step; a patient-specific drug-specific risk information determination step for determining risk information for each patient based on patient identification information, drug identification information, drug-taking period information, blank period information, compliance rate calculation rules, and risk information derivation rules; a risk information storage step of storing the risk information determined in the risk information determination step for determining risk information for each patient and each drug in association with the patient identification information and the drug identification information; 22. An operating program for a risk assessment system, which is written in a readable and executable manner by a risk assessment system which is a computer as claimed in claim 19 or 21, further comprising:

24. An operating program of a risk assessment system written in a readable and executable manner into the risk assessment system which is a computer as described in claim 23, characterized in that it further has an alert notification step of issuing an alert to alert both or either one of the drug recipient identified by the drug recipient identification information and the medical professionals involved with the drug recipient to pay attention, depending on the risk information retained in the risk information retention step.

25. a medication instruction advice information storage step of storing advice information regarding medication instruction for a drug prescribed to a medication recipient in association with medication recipient identification information; a medication instruction advice information updating step capable of updating advice information regarding medication instruction held in the medication instruction advice information holding step according to the risk information held in the risk information holding step; a medication instruction advice information output step of outputting the advice information regarding medication instruction updated in the medication instruction advice information update step to both or either one of a user identified by the user identification information and a medical professional related to the user; 24. An operating program for a risk assessment system, which is written in a readable and executable manner for a risk assessment system that is a computer as described in claim 23, further comprising:

26. An operating program for a risk assessment system written in a readable and executable manner for a risk assessment system which is a computer as described in claim 23, characterized in that it further has a risk information output step which can output the risk information retained in the risk information retention step to the outside based on the consent of the drug recipient identified by the drug recipient identification information.

27. An operating program of a risk assessment system written in a readable and executable manner by a risk assessment system which is a computer as described in claim 19 or claim 21, characterized in that the medication user identification information includes at least one of the following information: My Number information, the symbol and number of a social insurance or national health insurance certificate, and a long-term care insurance certificate number.

Images